info icon

Malignant neoplasm of respiratory system and intrathoracic organs

C3_RESPIRATORY_INTRATHORACIC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

9613

6. Filter based on genotype QC (FinnGen only)

9613

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4

Similar endpoints

List of similar endpoints to Malignant neoplasm of respiratory system and intrathoracic organs based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 9613 2451 7162
Unadjusted period prevalence (%) 2.57 0.84 3.16
Median age at first event (years) 71.17 68.59 72.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
8782
Matched controls
80795
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
323.0
467
*
L01CA04
ATC
vinorelbine; systemic
97.9
323.0
605
61
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
457.5
323.0
939
21
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
545.5
323.0
860
16
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
225.4
323.0
353
15
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
5877.7
323.0
1608
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
323.0
560
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
500.2
323.0
885
18
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.8
323.0
1343
2090
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
429.9
323.0
653
15
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
139.3
323.0
377
26
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
146.5
323.0
927
65
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
323.0
425
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.8
323.0
2559
7884
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
144.6
323.0
546
37
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
14.1
323.0
4082
4670
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2738.7
323.0
1090
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
114.5
323.0
438
37
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
49.7
323.0
2450
624
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.4
323.0
1088
1083
H02AB02
ATC
dexamethasone; systemic
8.7
323.0
2541
3596
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
7506.4
323.0
757
*
GDC00
NOMESCO Finland
Lobectomy of lung
138.9
323.0
592
42
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
448.8
323.0
1371
33
Z51.5
ICD-10 Finland
Palliative care
5.3
323.0
1481
2975
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
299.1
323.0
459
15
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
323.0
1139
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
370.8
323.0
498
13
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
142.3
323.0
685
48
A98
ICPC
Health maint/preventive medicine
0.4
323.0
4611
58961
WF004
NOMESCO Finland
Palliative radiotherapy
14.7
323.0
792
540
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
323.0
814
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
323.0
1000
1321
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
241.5
323.0
854
36
A03FA01
ATC
metoclopramide; systemic, rectal
4.9
323.0
3343
9005
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
18.4
323.0
982
548
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
1916.6
323.0
726
*
A04AA01
ATC
ondansetron; systemic, rectal
7.2
323.0
1379
2043
N02AA05
ATC
oxycodone; systemic
4.1
323.0
2767
8213
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.5
323.0
3273
3401
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
54.5
323.0
987
187
130
Kela drug reimbursment
Malignant tumour
17.0
323.0
3874
3585
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
323.0
940
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
91.9
323.0
832
92
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
323.0
346
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
777.1
322.6
326
*
GD1AD
NOMESCO Finland
Thorax CT examination
6.1
313.2
939
1565
R84
ICPC
Malignant neoplasm bronchus/lung
108.1
301.7
339
30
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
23.5
298.8
446
183
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
888.7
278.7
281
*
JN4BD
NOMESCO Finland
Extensive body CT
3.3
278.6
1665
5375
L01CB01
ATC
etoposide; systemic
86.1
274.1
316
35
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.8
273.1
1001
2094
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
865.8
271.6
274
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
301.4
271.0
283
9
WF002
NOMESCO Finland
Radical radiotherapy
4.7
267.0
1010
2182
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.9
266.0
455
277
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
8.5
262.6
614
708
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.3
261.3
881
1678
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
27.4
258.4
369
129
C45.0
ICD-10 Finland
Mesothelioma of pleura
254.9
254.5
268
10
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
90.3
248.6
285
30
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
243.3
240
*
R03BB04
ATC
tiotropium bromide; inhalant
2.8
230.4
1742
6509
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
543.8
226.2
231
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
222.9
220
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
220.4
3414
18438
TGD00
NOMESCO Finland
Needle biopsy of lung
39.2
211.6
277
67
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.0
209.5
505
608
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
1863.1
207.4
207
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
1815.1
202.4
202
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.0
198.3
1285
4301
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
32.9
191.8
261
75
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
309.5
190.8
199
6
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
307.9
189.8
198
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.2
189.4
636
1192
A04AA55
ATC
palonosetron, combinations; systemic
8.5
188.7
437
492
A04AA02
ATC
granisetron; systemic, transdermal
4.1
188.2
805
1932
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
33.0
184.5
251
72
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
442.2
183.8
189
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.8
181.0
844
2185
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
253.2
178.4
188
7
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
28.0
173.6
246
83
WZC30
NOMESCO Finland
Teaching
2.6
170.2
1422
5535
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
44.8
168.0
214
45
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
+∞
167.0
165
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.7
158.7
580
1187
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
158.6
610
1315
H02AB06
ATC
prednisolone; systemic
1.8
158.1
4294
27603
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
13.5
152.3
277
194
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
719.5
151.8
154
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.5
149.9
480
847
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
144.8
4182
27131
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.3
144.7
368
478
191
Kela drug reimbursment
Erlotinib
82.4
144.2
167
19
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
143.3
1129
4213
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
141.6
140
*
DQA10
NOMESCO Finland
Biopsy of larynx
20.7
138.9
215
98
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
138.1
1183
4626
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.8
132.8
475
947
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
418.4
131.0
135
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
8.6
130.1
299
331
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.9
129.7
314
378
1BA04
NOMESCO Finland
NA
610.1
128.6
131
*
155
Kela drug reimbursment
Afatinib and gefitinib
605.3
127.6
130
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
64.5
127.1
152
22
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.7
127.1
247
200
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
125.4
124
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
9.8
124.6
265
256
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
141.1
124.2
136
9
N02AA01
ATC
morphine; systemic, rectal
6.4
123.5
344
508
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
243.2
123.2
130
5
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
121.3
120
*
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
386.7
121.0
125
*
JN4AD
NOMESCO Finland
Body CT examination
2.6
118.1
934
3471
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
117.7
727
2307
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.1
116.4
396
746
J01MA14
ATC
moxifloxacin; systemic
2.5
116.0
1001
3904
L01XE03
ATC
[U] erlotinib; oral
74.2
115.2
135
17
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
93.4
114.1
130
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
113.1
1760
9013
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
112.4
2550
14940
TGA30
NOMESCO Finland
Thoracocentesis
8.9
108.8
243
256
R04.2
ICD-10 Finland
Haemoptysis
3.4
107.5
575
1642
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
339.2
106.0
110
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
135.1
105.6
116
8
5826
FHL
Lobectomy or bilobectomy
54.7
105.2
129
22
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.1
105.0
440
1023
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
71.8
104.5
123
16
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
32.9
104.0
141
40
GDD00
NOMESCO Finland
Pneumonectomy
203.0
102.2
109
5
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
17.7
102.0
166
88
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
77.9
100.5
117
14
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
477.5
100.5
103
*
A06AH03
ATC
naloxegol; oral
8.1
100.2
237
275
J94.8
ICD-10 Finland
Other specified pleural conditions
4.9
99.0
343
659
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
96.8
2597
33037
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
237.6
96.6
102
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
96.3
802
3052
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.6
96.2
1764
24583
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
96.0
95
*
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
453.9
95.4
98
*
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
93.0
92
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
9.2
91.1
199
202
8000/3-C34.3
ICD-O-3
Neoplasm, malignant of lower lobe, lung
+∞
90.9
90
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
24.3
90.8
133
51
A04AD12
ATC
aprepitant; systemic
6.2
90.1
257
391
ZX120
NOMESCO Finland
Intravenous
2.3
90.1
981
4274
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.0
90.1
582
1894
R03BB01
ATC
ipratropium bromide; inhalant
2.6
89.9
730
2735
J93.8
ICD-10 Finland
Other pneumothorax
14.6
89.1
156
100
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
49.2
89.0
111
21
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.8
88.4
311
607
N07BA03
ATC
varenicline; oral
4.0
88.2
381
910
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
93.0
87.8
100
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.6
87.7
327
678
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
87.0
1203
5814
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
11.3
87.0
171
142
J01MA12
ATC
levofloxacin; systemic
1.8
86.7
1914
10949
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
86.2
1717
23605
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
86.2
295
559
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
12.3
85.6
161
122
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
85.2
2170
28201
DQB30
NOMESCO Finland
Laryngectomy
169.1
84.4
91
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
9.6
84.0
179
174
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
83.7
3657
42451
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
83.0
792
3230
L01XE13
ATC
[U] afatinib; oral
+∞
81.8
81
*
GEA00
NOMESCO Finland
Mediastinoscopy
20.6
81.8
126
57
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
8.9
81.5
182
192
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
14.6
81.2
142
91
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.1
80.3
332
761
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
118.1
80.2
89
7
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
27.7
80.0
113
38
XG410
NOMESCO Finland
Flow-volume spirometry
2.9
78.6
509
1658
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.7
78.5
177
190
N02AX02
ATC
tramadol; systemic, rectal
1.5
77.9
3601
25023
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
77.8
1297
18732
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
369.2
77.4
80
*
C34.17
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary carcinoid
713.2
75.9
77
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
19.8
75.1
117
55
GDC10
NOMESCO Finland
Bilobectomy of lung
245.0
75.0
79
*
C34.37
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung carcinoid
355.0
74.4
77
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
74.2
959
14832
N06DX01
ATC
memantine; oral
0.3
74.2
144
4567
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
22.5
74.1
111
46
P20
ICPC
Memory disturbance
0.4
73.1
414
8293
L03AA13
ATC
pegfilgrastim; parenteral
3.4
72.4
372
1026
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
13.1
72.3
132
94
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
16.2
71.7
120
69
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
71.2
1842
24121
R03AC02
ATC
salbutamol; inhalant
1.5
71.0
3755
26712
R85
ICPC
Malignant neopl respiratory other
44.0
70.9
90
19
SPAT1053
SPAT
Memory test
0.5
70.8
627
10830
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
13.8
70.6
126
85
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
70.0
1595
21498
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
69.9
1018
15284
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.3
69.1
222
392
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
7.5
68.1
168
209
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.2
67.5
157
178
WX250
NOMESCO Finland
Intercostal blockade
25.5
66.6
96
35
1240
FHL
Bronchoscopy
4.6
66.2
241
488
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
24.8
66.1
96
36
3004
Kela drug reimbursment
Osimertinib
619.6
65.9
67
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
65.8
670
11124
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
65.6
65
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
65.4
1971
25114
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.8
65.4
230
449
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
65.0
723
3160
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.0
63.8
216
405
UJC01
NOMESCO Finland
Scopy of lower throat
6.4
63.4
176
259
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.3
63.0
346
1003
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
10.8
63.0
126
109
341
Kela drug reimbursment
Afatinib and gefitinib
582.2
61.9
63
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.6
61.7
292
754
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
30.0
60.9
84
26
8250/3-C34.9
ICD-O-3
Lepidic adenocarcinoma of lung, NOS
+∞
60.6
60
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
60.1
1716
10419
GAC00
NOMESCO Finland
Biopsy of pleura
9.6
59.9
127
123
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
563.5
59.8
61
*
SPAT1325
SPAT
Vaccination
0.6
59.7
1649
21484
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
59.5
1315
7414
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
59.1
2061
13168
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
148.2
58.9
64
*
1519
Kela drug reimbursment
NA
554.1
58.8
60
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.9
58.7
203
390
K02.1
ICD-10 Finland
Caries of dentine
0.7
58.6
1970
24697
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
87.4
57.7
66
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.6
57.7
461
1699
TGC00
NOMESCO Finland
Bronchial lavation
3.3
57.6
310
886
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
57.5
574
9621
XKD00
NOMESCO Finland
Uroflowmetry
0.6
57.2
910
13456
ZX095
NOMESCO Finland
Combined chemoradiotherapy
9.0
56.7
125
130
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
56.5
56
*
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
28.2
56.5
79
26
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
56.0
1168
16213
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
526.1
55.8
57
*
C10AA05
ATC
atorvastatin; oral
0.7
55.7
2059
25414
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
55.6
823
12403
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
55.5
55
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.5
55.5
136
168
GAA31
NOMESCO Finland
Thoracoscopy
14.3
55.4
97
63
R03DA04
ATC
theophylline; systemic, rectal
2.0
55.3
784
3784
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
12.3
55.0
103
78
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.0
54.7
230
536
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.9
54.0
158
250
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
+∞
53.5
53
*
S18
ICPC
Laceration/cut
0.7
53.4
1951
24185
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.4
53.4
202
426
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.3
53.4
170
298
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
52.9
157
4092
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.9
52.8
345
1126
L03AA02
ATC
filgrastim; parenteral
3.3
52.3
283
812
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
7.3
52.2
131
168
SPAT1312
SPAT
General health counselling
0.6
51.8
1100
15251
8551/3-C34.1
ICD-O-3
Acinar cell cystadenocarcinoma of upper lobe, lung
+∞
51.5
51
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
50.9
1000
14116
L01EB04
ATC
osimertinib; oral
479.4
50.8
52
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
50.7
1751
11099
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
+∞
50.5
50
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
166.5
50.2
54
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
11.9
50.2
95
74
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.6
50.1
1307
17355
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
50.0
427
7523
1CD01
NOMESCO Finland
NA
20.7
49.8
76
34
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
49.5
498
8359
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
49.5
49
*
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
+∞
49.5
49
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.1
49.5
202
459
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
163.4
49.2
53
*
KMAK
NOMESCO Finland
NA
0.7
49.1
1782
22201
WX892
NOMESCO Finland
Monitored bed care
2.0
49.0
717
3497
SPAT1301
SPAT
No procedures
0.6
48.8
1390
18149
C10AA07
ATC
rosuvastatin; oral
0.6
48.6
869
12555
SPAT1153
SPAT
Removal of sutures
0.6
48.3
1372
17930
DQB70
NOMESCO Finland
Total excision of vocal cord
99.9
48.0
54
5
SPAT1249
SPAT
Treatment-related counselling outside office
0.7
48.0
1617
20452
H13
ICPC
Plugged feeling ear
0.6
48.0
664
10223
L15
ICPC
Knee symptom/complaint
0.5
47.9
548
8873
SPAT1310
SPAT
Counselling related to known health issue
0.6
47.8
1199
16079
L57.0
ICD-10 Finland
Actinic keratosis
0.5
47.8
308
5950
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.6
47.6
820
11957
D82
ICPC
Teeth/gum disease
0.6
47.0
893
12732
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
9.6
46.8
99
96
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
442.1
46.8
48
*
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
46.4
46
*
8240/3-C34.3
ICD-O-3
Neuroendocrine tumor, NOS, of lower lobe, lung
+∞
46.4
46
*
J93.9
ICD-10 Finland
Pneumothorax, unspecified
8.0
46.3
109
127
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.8
46.0
316
1066
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.2
45.8
106
120
WW200
SPAT
NA
0.3
45.7
108
3124
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
45.5
647
9901
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
45.4
532
2369
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
45.1
1626
10371
Z01.2
ICD-10 Finland
Dental examination
0.6
44.9
1216
16086
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.7
44.9
1688
20976
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.4
44.7
259
5194
PJD99
NOMESCO Finland
Excision of other lymph nodes
50.9
44.7
55
10
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
44.4
44
*
R4110
NOMESCO Finland
Physiotherapy
1.5
44.4
1995
13362
A79
ICPC
Malignancy NOS
4.1
44.2
183
422
N03AX16
ATC
pregabalin; oral
1.5
43.8
1687
10913
WW500
NOMESCO Finland
Blood transfusion
2.4
43.7
406
1623
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.4
43.5
165
350
B01AB05
ATC
enoxaparin; parenteral
1.4
43.4
2401
16755
C37
ICD-10 Finland
Malignant neoplasm of thymus
144.8
43.3
47
*
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
144.8
43.3
47
*
N06DA02
ATC
donepezil; oral
0.4
42.5
153
3682
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
42.2
557
2608
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.4
42.0
145
3546
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.5
41.6
396
6772
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
41.4
41
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
41.3
529
2445
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.8
41.1
275
913
G04CA02
ATC
tamsulosin; oral
0.7
40.9
1903
22873
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
40.9
2021
24049
M01AH05
ATC
etoricoxib; oral
0.7
40.8
2382
27597
N05CF01
ATC
zopiclone; oral
1.4
40.8
2733
19709
JN4CD
NOMESCO Finland
Very extensive body CT
2.3
40.7
410
1703
L17
ICPC
Foot/toe symptom/complaint
0.6
40.5
879
12210
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
40.4
40
*
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
39.9
72
2381
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
39.6
431
7101
5828
FHL
Pneumectomy
194.0
39.5
42
*
J86.9
ICD-10 Finland
Pyothorax without fistula
4.7
39.4
140
278
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
+∞
39.4
39
*
L01XE02
ATC
[U] gefitinib; oral
367.5
38.8
40
*
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
38.5
962
12991
C09CA01
ATC
losartan; oral
0.6
38.3
1023
13632
L03AA14
ATC
lipegfilgrastim; parenteral
3.9
38.0
162
384
H02
ICPC
Hearing complaint
0.5
37.9
407
6733
B01AB10
ATC
tinzaparin; parenteral
1.9
37.9
568
2789
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
358.2
37.8
39
*
SPAT1043
SPAT
Audiometry
0.5
37.8
317
5637
SPAT1263
SPAT
Sampling
0.7
37.4
1933
22916
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.6
37.3
588
8807
Z72.0
ICD-10 Finland
Tobacco use
3.3
37.3
196
552
M79.6
ICD-10 Finland
Pain in limb
0.7
37.2
1341
16899
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
47.2
37.0
46
9
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
47.2
37.0
46
9
D19
ICPC
Teeth/gum symptom/complaint
0.6
36.9
616
9096
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
5.0
36.8
123
229
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
180.1
36.5
39
*
G47.3
ICD-10 Finland
Sleep apnoea
0.6
36.5
662
9594
1BC05
NOMESCO Finland
NA
94.7
36.4
41
*
JN6AD
NOMESCO Finland
CT of torso and neck
4.2
36.3
145
324
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
36.3
36
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
36.3
1025
13526
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
36.3
1184
15204
R06.0
ICD-10 Finland
Dyspnoea
1.4
36.2
2034
14145
G04BD12
ATC
mirabegron; oral
0.5
36.0
289
5214
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
35.8
417
1851
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
38.6
35.6
46
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
35.6
429
1933
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.6
35.4
759
10607
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
41.6
35.4
45
10
M01AX05
ATC
glucosamine; oral
0.6
35.3
825
11320
L01XX17
ATC
[U] topotecan; systemic
+∞
35.3
35
*
8046/3-C34.9
ICD-O-3
Non-small cell carcinoma of lung, NOS
+∞
35.3
35
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
35.3
180
3784
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.5
35.2
175
473
B01AF01
ATC
rivaroxaban; oral
0.5
35.1
368
6132
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
35.1
1922
22632
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
170.8
34.6
37
*
8480/3-C34.3
ICD-O-3
Mucinous adenocarcinoma of lower lobe, lung
+∞
34.3
34
*
Z51.0
ICD-10 Finland
Radiotherapy session
3.7
34.3
157
397
L82
ICD-10 Finland
Seborrhoeic keratosis
0.6
33.8
459
7146
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.6
33.8
610
8862
ZXC10
NOMESCO Finland
Use of laser
2.9
33.7
211
672
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
166.2
33.6
36
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.5
33.6
365
6026
C10AA01
ATC
simvastatin; oral
0.8
33.5
3029
33243
K03.64
ICD-10 Finland
Dental calculus supragingival
0.6
33.3
625
9003
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.4
33.3
184
3759
L13
ICPC
Hip symptom/complaint
0.6
33.2
470
7240
ZX080
NOMESCO Finland
Image guided radiotherapy
3.2
33.2
186
550
B02AA02
ATC
tranexamic acid; systemic
1.7
33.2
793
4526
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.9
33.0
143
345
A06AD11
ATC
lactulose; oral
1.5
33.0
1503
10007
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
32.9
346
1467
G04CB02
ATC
dutasteride; oral
0.5
32.8
301
5218
3001
Kela drug reimbursment
Alectinib
311.6
32.8
34
*
J43.9
ICD-10 Finland
Emphysema, unspecified
2.8
32.7
221
740
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.7
32.7
97
158
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
32.7
1910
22324
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
70.3
32.6
38
5
1610A
ICD-9 Finland
Malignant neoplasm of larynx, Glottis
161.6
32.6
35
*
8551/3-C34.3
ICD-O-3
Acinar cell cystadenocarcinoma of lower lobe, lung
+∞
32.3
32
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
13.1
32.3
58
41
J01DB01
ATC
cefalexin; oral
0.8
32.3
4826
49716
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.6
32.2
587
8514
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
11.0
31.9
62
52
T90
ICPC
Diabetes non-insulin dependent
0.7
31.9
1054
13545
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
302.2
31.8
33
*
1504
Kela drug reimbursment
Alectinib
302.2
31.8
33
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.6
31.8
244
881
Z00.0
ICD-10 Finland
General medical examination
0.6
31.6
639
9060
F03
ICD-10 Finland
Unspecified dementia
0.4
31.4
149
3218
L03
ICPC
Low back symptom/complaint
0.6
31.3
708
9801
8010/3-C34.3
ICD-O-3
Carcinoma, NOS, of lower lobe, lung
+∞
31.3
31
*
8240/3-C34.1
ICD-O-3
Neuroendocrine tumor, NOS, of upper lobe, lung
+∞
31.3
31
*
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
31.3
31
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.3
31.2
75
2156
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
34.5
31.1
41
11
GBB00
NOMESCO Finland
Tracheostomy
3.4
30.8
156
428
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
8.3
30.8
70
78
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.3
30.8
92
2397
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
152.3
30.6
33
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
16.5
30.6
50
28
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
8.2
30.6
70
79
C08CA01
ATC
amlodipine; oral
0.7
30.6
2087
23904
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.7
30.5
1372
16743
B01AF02
ATC
apixaban; oral
0.5
30.4
350
5696
WX402
NOMESCO Finland
General anaesthesia
1.6
30.4
958
5872
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
30.3
814
10894
G20
ICD-10 Finland
Parkinson disease
0.3
30.3
57
1844
8046/3-C34.1
ICD-O-3
Non-small cell carcinoma of upper lobe, lung
+∞
30.3
30
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
30.2
406
1909
N02BE01
ATC
paracetamol; systemic, rectal
0.8
30.0
5544
55897
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.7
29.9
1422
17206
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
14.7
29.9
51
32
C45.9
ICD-10 Finland
Mesothelioma, unspecified
55.4
29.9
36
6
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
29.8
1667
19674
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
29.8
281
4834
G04CA01
ATC
alfuzosin; oral
0.6
29.4
663
9196
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
5.8
29.4
86
138
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
27.0
29.4
41
14
205
Kela drug reimbursment
Chronic hypertension
0.7
29.3
1960
22549
L01XE35
ATC
[U] osimertinib; oral
+∞
29.3
29
*
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
29.3
29
*
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
29.3
29
*
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.5
29.2
140
369
A07AA02
ATC
nystatin; oral
1.8
29.1
500
2575
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
29.0
3157
24233
D01BA02
ATC
terbinafine; oral; topical
0.7
29.0
1040
13197
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
16.7
28.9
47
26
VALMI
NOMESCO Finland
NA
0.6
28.9
605
8523
5188X
ICD-9 Finland
Other diseases of lung
6.3
28.7
78
114
1420
FHL
Laryngomicroscopy
3.9
28.7
121
286
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
16.1
28.6
47
27
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
28.5
1511
18005
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
28.5
1143
7391
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
7.1
28.5
71
92
169
Kela drug reimbursment
Crizotinib
+∞
28.3
28
*
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
+∞
28.3
28
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.6
28.2
682
9328
UGB02
NOMESCO Finland
Tracheoscopy
13.2
28.1
50
35
WX600
NOMESCO Finland
Single shot through catheter
4.2
27.7
109
242
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
6.5
27.7
74
106
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
27.5
1713
19942
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.6
27.4
485
7098
R95
ICPC
Chron obstructive pulmonary disease
2.2
27.4
297
1277
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
11.4
27.3
52
42
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
44.8
27.3
34
7
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.3
27.2
105
229
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.4
27.2
130
2801
207
Kela drug reimbursment
Chronic arrhythmias
0.7
27.2
767
10182
L08
ICPC
Shoulder symptom/complaint
0.6
27.0
598
8330
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
27.0
395
1922
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.8
26.9
119
294
WX734
NOMESCO Finland
JET-ventilation
17.3
26.9
43
23
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
259.6
26.8
28
*
L01ED03
ATC
alectinib; oral
259.6
26.8
28
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
26.5
245
4246
R4190
NOMESCO Finland
Nutritional therapy
2.6
26.5
205
745
UKC02
NOMESCO Finland
Cystoscopy
0.7
26.5
966
12246
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
26.5
904
11595
UGC02
NOMESCO Finland
Rigid bronchoscopy
9.2
26.4
56
56
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.5
26.3
221
841
SPAT1109
SPAT
Analgesia with portable analgesic pump
4.7
26.3
92
182
K78
ICPC
Atrial fibrillation/flutter
0.6
26.3
312
5038
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
+∞
26.2
26
*
L01EB03
ATC
afatinib; oral
+∞
26.2
26
*
XG460
NOMESCO Finland
Short time oxymetry
2.5
26.1
215
807
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
0.7
25.9
678
9141
H81
ICPC
Excessive ear wax
0.7
25.9
720
9592
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
250.0
25.8
27
*
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
24.4
25.8
37
14
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
25.8
66
1843
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
89.2
25.7
29
*
GBB13
NOMESCO Finland
Revision of tracheostomy
17.2
25.6
41
22
C10AX09
ATC
ezetimibe; oral
0.6
25.4
322
5115
C34.84
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
25.2
25
*
8010/3-C34.1
ICD-O-3
Carcinoma, NOS, of upper lobe, lung
+∞
25.2
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
25.2
1015
6559
N05AX08
ATC
risperidone; systemic
0.5
25.1
242
4143
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.5
25.1
252
4262
SPAT1260
SPAT
Consultation of another employee
0.7
25.0
636
8627
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
10.3
25.0
50
45
S29
ICPC
Skin symptom/complaint other
0.6
24.9
561
7794
C34.27
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung carcinoid
240.4
24.8
26
*
M54.5
ICD-10 Finland
Low back pain
0.7
24.8
1145
13984
WX330
NOMESCO Finland
Paravertebral ansthesia
67.0
24.8
29
*
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
2.6
24.8
183
646
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
24.8
1546
18049
K86
ICPC
Hypertension uncomplicated
0.6
24.7
404
6027
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.7
24.6
612
8340
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
0.7
24.6
857
10962
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
12.2
24.5
45
34
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
24.4
98
2256
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
+∞
24.2
24
*
8250/3-C34.1
ICD-O-3
Lepidic adenocarcinoma of upper lobe, lung
+∞
24.2
24
*
L01XE36
ATC
[U] alectinib; oral
+∞
24.2
24
*
8246/3-C34.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of lung, NOS
+∞
24.2
24
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
24.2
94
2192
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.3
24.1
91
195
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
24.1
1026
12693
M05BX04
ATC
denosumab; parenteral
1.9
24.0
369
1825
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
24.0
231
941
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
23.9
102
2296
B01AB04
ATC
dalteparin; parenteral
1.8
23.9
414
2138
A06AC01
ATC
ispaghula (psylla seeds); oral
0.7
23.9
1022
12638
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.5
23.8
203
3601
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
23.7
304
4818
GDA10
NOMESCO Finland
Biopsy of lung
9.2
23.7
50
50
J01AA02
ATC
doxycycline; systemic
1.3
23.6
5836
49205
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
29.5
23.6
32
10
M16.1
ICD-10 Finland
Other primary coxarthrosis
0.6
23.5
431
6266
M25.5
ICD-10 Finland
Pain in joint
0.7
23.4
856
10872
A10BA02
ATC
metformin; oral
0.8
23.4
1599
18461
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.5
23.3
267
4361
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.7
23.3
698
9185
8250/3-C34.3
ICD-O-3
Lepidic adenocarcinoma of lower lobe, lung
+∞
23.2
23
*
1623G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,VAIN SYTOL DG]
+∞
23.2
23
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.6
23.1
524
7277
C08CA13
ATC
lercanidipine; oral
0.6
23.1
503
7043
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
11.7
23.0
43
34
A04AA03
ATC
tropisetron; systemic
8.4
22.9
51
56
C34.05
ICD-10 Finland
Malignant tumor of the main bronchial other non-microcellular carcinoma
221.3
22.9
24
*
325
Kela drug reimbursment
Erlotinib
221.3
22.9
24
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
22.8
419
2204
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.6
22.8
437
6293
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
22.8
691
9070
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.6
22.6
170
609
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.0
22.5
92
213
P70
ICPC
Dementia
0.2
22.3
28
1126
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.3
22.3
69
120
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
22.2
22
*
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
+∞
22.2
22
*
L01XE16
ATC
[U] crizotinib; oral
+∞
22.2
22
*
8000/3-C34.0
ICD-O-3
Neoplasm, malignant of main bronchus
+∞
22.2
22
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
22.2
22
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
4.9
22.2
74
140
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.5
22.2
151
2876
C09CA06
ATC
candesartan; oral
0.7
22.2
788
10063
SPAT1097
SPAT
Recording of ECG
0.7
22.1
596
8004
DHA10
NOMESCO Finland
Biopsy of cavity of nose
4.3
22.0
83
178
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.1
22.0
88
200
GD6AD
NOMESCO Finland
CT of chest and neck
7.9
22.0
51
60
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.3
21.9
62
1652
G30.8
ICD-10 Finland
Other Alzheimer disease
0.3
21.8
40
1310
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.1
21.8
243
1059
J38.3
ICD-10 Finland
Other diseases of vocal cords
3.6
21.6
100
258
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.0
21.5
130
408
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.2
21.4
113
323
H02AB07
ATC
prednisone; oral
1.4
21.4
1098
7423
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.6
21.3
262
4195
C34.04
ICD-10 Finland
Malignant tumor of the main bronchial macrocellular anaplastic carcinoma
+∞
21.2
21
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
202.8
20.9
22
*
GDB10
NOMESCO Finland
Wedge resection of lung
8.8
20.9
45
47
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.4
20.9
105
290
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
20.6
170
641
-1
NOMESCO Finland
NA
0.7
20.5
1039
12547
R31
ICD-10 Finland
Unspecified haematuria
0.7
20.5
549
7384
R42
ICD-10 Finland
Dizziness and giddiness
0.7
20.4
1006
12200
I50.0
ICD-10 Finland
Congestive heart failure
0.6
20.3
419
5940
A02BA02
ATC
ranitidine; systemic
1.3
20.3
1619
11768
R03AC13
ATC
formoterol; inhalant
1.8
20.3
380
2015
I87.1
ICD-10 Finland
Compression of vein
10.9
20.3
39
33
K80
ICPC
Cardiac arrhythmia NOS
0.5
20.2
161
2918
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
20.2
20
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
20.2
1192
8259
S82
ICPC
Naevus/mole
0.6
20.0
313
4724
H91.1
ICD-10 Finland
Presbycusis
0.6
20.0
249
3978
116
Kela drug reimbursment
Prostate cancer
0.6
19.9
365
5314
C38.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura
70.8
19.9
23
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.8
19.9
1742
19554
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
19.8
292
4473
RS221
NOMESCO Finland
NA
3.1
19.8
113
342
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.6
19.6
300
4551
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.7
19.4
659
8497
H26.4
ICD-10 Finland
After-cataract
0.6
19.4
366
5294
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
19.4
1241
14513
L90
ICPC
Osteoarthrosis of knee
0.5
19.3
124
2408
ZYC01
SPAT
NA
0.3
19.3
54
1446
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
10.3
19.2
38
34
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
19.2
19
*
C34.87
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary carcinoid
+∞
19.2
19
*
GD003
NOMESCO Finland
Adjuvant radiotherapy of trachea, bronchi and lungs
+∞
19.2
19
*
C34.83
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma
+∞
19.2
19
*
S01ED51
ATC
timolol, combinations; ophthalmic
0.6
19.2
283
4332
R05CB01
ATC
acetylcysteine; inhalant, oral
2.2
18.9
191
800
WX320
NOMESCO Finland
Spinalanesthesy
0.7
18.8
992
11930
SPAT1305
SPAT
Counselling and guidance related to physical exercise
0.6
18.8
279
4267
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
18.7
1048
7184
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
0.7
18.7
974
11731
GB3AV
NOMESCO Finland
NA
22.6
18.6
27
11
H61.2
ICD-10 Finland
Impacted cerumen
0.5
18.6
133
2490
SPAT1216
SPAT
Assessment of functional ability
0.7
18.5
733
9214
J01MA02
ATC
ciprofloxacin; systemic
0.8
18.5
2303
24869
A97
ICPC
No disease
0.7
18.4
507
6787
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.6
18.3
238
3759
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
18.2
18
*
8582/3-C37.9
ICD-O-3
Thymoma, type AB of thymus
+∞
18.2
18
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.2
18
*
C34.25
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma
+∞
18.2
18
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
18.2
18
*
1623E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA ALIA DEF/NUD]
+∞
18.2
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
0.6
18.1
245
3835
DFF00
NOMESCO Finland
Pure tone audiometry
0.6
18.1
275
4179
SPAT1304
SPAT
Counselling and guidance related to ageing
0.6
18.1
260
4009
DHB10
NOMESCO Finland
Excision of lesion of internal nose
5.9
18.1
51
80
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.7
18.0
80
201
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
11.2
18.0
34
28
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
175.1
17.9
19
*
C32
ICD-10 Finland
Malignant neoplasm of larynx
92.2
17.9
20
*
A02BC02
ATC
pantoprazole; systemic
1.2
17.9
4721
39421
J01FA06
ATC
roxithromycin; oral
1.2
17.9
2714
21371
R5140
NOMESCO Finland
Monitoring the use of the aid
0.6
17.8
317
4649
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.7
17.8
719
9012
B01AA03
ATC
warfarin; systemic
0.8
17.8
1543
17387
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
17.8
388
2151
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
17.7
236
3704
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.6
17.7
347
4978
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.7
17.7
539
7089
C09AA02
ATC
enalapril; systemic
0.8
17.6
1235
14293
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
40.5
17.5
22
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
17.5
1408
16012
XJH00
NOMESCO Finland
Transanal ultrasonography
0.6
17.4
364
5154
H40.0
ICD-10 Finland
Glaucoma suspect
0.6
17.4
204
3311
M01AC06
ATC
meloxicam; systemic, rectal
0.8
17.4
1582
17730
SGA01
NOMESCO Finland
Tooth opening as first aid
0.6
17.4
285
4259
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
10.5
17.4
34
30
UJF32
NOMESCO Finland
Coloscopy
0.8
17.3
1287
14789
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
0.5
17.2
191
3146
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
17.1
17
*
8046/3-C34.3
ICD-O-3
Non-small cell carcinoma of lower lobe, lung
+∞
17.1
17
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.7
17.0
521
6848
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
0.5
17.0
130
2386
R01AD12
ATC
fluticasone furoate; nasal
0.7
17.0
767
9449
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
16.6
16.9
27
15
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
0.6
16.9
220
3471
R03AC12
ATC
salmeterol; inhalant
1.6
16.9
410
2344
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.5
16.8
164
2796
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
9.2
16.8
35
35
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
16.8
1163
8254
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
3.2
16.7
90
263
GEC23
NOMESCO Finland
Transsternal thymectomy
19.2
16.5
25
12
HMAK
NOMESCO Finland
NA
0.6
16.5
257
3881
OAB42
SPAT
NA
0.4
16.4
50
1286
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.7
16.4
806
9809
N17
ICPC
Vertigo/dizziness
0.6
16.4
349
4925
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.5
16.3
176
2922
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
2.7
16.3
113
389
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
1.9
16.2
242
1190
SFA00
NOMESCO Finland
Small filling
0.6
16.2
301
4370
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.3
16.2
83
235
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
23.6
16.1
23
9
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
23.6
16.1
23
9
8013/3-C34.9
ICD-O-3
Large cell neuroendocrine carcinoma of lung, NOS
+∞
16.1
16
*
8246/3-C34.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper lobe, lung
+∞
16.1
16
*
1625E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA ALIA DEF/NUD]
+∞
16.1
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.1
16
*
8020/3-C34.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of lung, NOS
+∞
16.1
16
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.5
16.1
141
2484
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
7.5
16.1
38
47
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
2.8
16.1
105
350
WX110
NOMESCO Finland
Local anesthesy
0.8
16.0
3400
34983
R52.0
ICD-10 Finland
Acute pain
2.1
16.0
177
772
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.1
16.0
177
772
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
32.3
16.0
21
6
I50.9
ICD-10 Finland
Heart failure, unspecified
0.8
15.9
993
11684
M70.6
ICD-10 Finland
Trochanteric bursitis
0.6
15.8
299
4325
N05AD01
ATC
haloperidol; systemic
1.8
15.7
287
1513
S02.51
ICD-10 Finland
Fracture of tooth, open
0.6
15.7
192
3076
K85
ICPC
Elevated blood pressure
0.7
15.6
591
7497
WZA90
NOMESCO Finland
Other doctors statement
0.7
15.6
718
8831
AN1
HP
Coronary angiography
0.7
15.6
665
8271
D06BB10
ATC
imiquimod; topical
0.4
15.5
86
1752
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
15.5
425
5699
-44
ICPC
Preventive immunization/medic
0.6
15.5
290
4200
J96.1
ICD-10 Finland
Chronic respiratory failure
1.9
15.4
239
1192
A10BK01
ATC
dapagliflozin; oral
0.4
15.4
64
1450
D01AE16
ATC
amorolfine; topical
0.7
15.3
413
5562
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
19.3
15.2
23
11
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.6
15.2
221
3394
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
55.3
15.2
18
*
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
+∞
15.1
15
*
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
15.1
15
*
C34.03
ICD-10 Finland
Malignant tumor of the main bronchial bronchoalveolar carcinoma
+∞
15.1
15
*
363
Kela drug reimbursment
Crizotinib
+∞
15.1
15
*
8480/3-C34.9
ICD-O-3
Mucinous adenocarcinoma of lung, NOS
+∞
15.1
15
*
H25.8
ICD-10 Finland
Other senile cataract
0.7
15.1
566
7194
U07
ICPC
Urine symptom/complaint other
0.5
15.1
129
2285
L12
ICPC
Hand/finger symptom/complaint
0.7
15.0
386
5242
114
Kela drug reimbursment
Glaucoma
0.7
14.9
412
5520
A10BK03
ATC
empagliflozin; oral
0.5
14.8
150
2530
DFF15
NOMESCO Finland
Speech audiometry
0.5
14.8
116
2112
1440
FHL
Mediastinoscopy
10.3
14.8
29
26
GDB20
NOMESCO Finland
Segmental resection of lung
20.3
14.8
22
10
M10.9
ICD-10 Finland
Gout, unspecified
0.6
14.8
268
3913
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
3.7
14.8
64
159
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.5
14.7
143
2443
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
0.6
14.7
274
3978
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
0.4
14.7
74
1561
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
14.7
61
146
R00.1
ICD-10 Finland
Bradycardia, unspecified
0.5
14.6
93
1808
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.4
14.6
126
490
N05BA04
ATC
oxazepam; oral
1.3
14.6
1603
12099
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
14.6
773
5239
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
5.3
14.6
44
76
N04BD01
ATC
selegiline; oral
0.2
14.6
17
707
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.3
14.6
32
956
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
7.2
14.5
35
45
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.8
14.5
61
148
WX290
NOMESCO Finland
Other blockade of nerve
0.8
14.5
1374
15373
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
14.8
14.5
24
15
KED22
NOMESCO Finland
Transurethral resection of prostate
0.7
14.5
397
5328
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
3.6
14.4
65
167
U02
ICPC
Urinary frequency/urgency
0.7
14.4
347
4775
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.1
14.4
79
236
WF099
NOMESCO Finland
Other radiotherapy
4.0
14.4
57
131
N02AC04
ATC
dextropropoxyphene; oral
1.6
14.4
373
2174
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
0.6
14.3
259
3782
L02BB03
ATC
bicalutamide; oral
0.5
14.3
138
2359
N06DA04
ATC
galantamine; oral
0.4
14.2
49
1194
8012/3-C34.1
ICD-O-3
Large cell carcinoma, NOS, of upper lobe, lung
+∞
14.1
14
*
8240/3-C34.2
ICD-O-3
Neuroendocrine tumor, NOS, of middle lobe, lung
+∞
14.1
14
*
8480/3-C34.1
ICD-O-3
Mucinous adenocarcinoma of upper lobe, lung
+∞
14.1
14
*
8000/3-C38.4
ICD-O-3
Neoplasm, malignant of pleura, NOS
+∞
14.1
14
*
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
14.1
14
*
8000/3-C34.2
ICD-O-3
Neoplasm, malignant of middle lobe, lung
+∞
14.1
14
*
R33
ICD-10 Finland
Retention of urine
0.7
14.1
498
6391
R03BB02
ATC
oxitropium bromide; inhalant
2.5
14.1
107
390
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.6
14.1
226
3388
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
73.8
14.0
16
*
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
15.1
14.0
23
14
Z57.2
ICD-10 Finland
Occupational exposure to dust
4.4
14.0
50
104
J01CA08
ATC
pivmecillinam; oral
0.8
14.0
1173
13322
C09AA05
ATC
ramipril; oral
0.8
14.0
1591
17460
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
138.2
14.0
15
*
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
138.2
14.0
15
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.6
14.0
103
370
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
2.0
13.9
172
790
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.6
13.9
285
4050
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.7
13.9
341
4673
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.4
13.9
113
428
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.9
13.9
56
131
N87
ICPC
Parkinsonism
0.2
13.8
13
615
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
0.6
13.8
165
2662
R4110
SPAT
NA
0.3
13.8
28
867
TGB20
NOMESCO Finland
Tracheostomy tube replacement
10.9
13.7
26
22
SPAT1148
SPAT
Treatment of chronic ulcer or burn
0.7
13.6
654
7997
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
0.5
13.6
111
1991
C09DA01
ATC
losartan and diuretics; oral
0.7
13.5
380
5078
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.0
13.5
77
234
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
0.4
13.5
51
1199
OAA67
SPAT
NA
0.3
13.4
30
885
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.6
13.4
271
3864
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
13.4
21
741
E0000UV
ATC
NA
0.8
13.4
1805
19480
GBB96
NOMESCO Finland
Other tracheostomy procedure
9.6
13.4
27
26
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.7
13.4
323
4443
C08CA02
ATC
felodipine; oral
0.7
13.3
463
5958
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
0.6
13.3
191
2939
Y77
ICPC
Malignant neoplasm prostate
0.5
13.2
107
1925
8013/3-C34.1
ICD-O-3
Large cell neuroendocrine carcinoma of upper lobe, lung
+∞
13.1
13
*
8249/3-C34.3
ICD-O-3
Neuroendocrine tumor, grade 2 of lower lobe, lung
+∞
13.1
13
*
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
13.1
13
*
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
13.1
13
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
13.1
13
*
1622X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,EI HIST/SYTOL DG]
+∞
13.1
13
*
1611A
ICD-9 Finland
Malignant neoplasm of larynx, Supraglottis
+∞
13.1
13
*
L01CE01
ATC
topotecan; systemic
+∞
13.1
13
*
4504
FHL
Laryngectomy
+∞
13.1
13
*
ZXC50
NOMESCO Finland
Cryotherapy
0.4
13.1
70
1441
C34.93
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma
69.2
13.1
15
*
SPAT1101
SPAT
Orthostatic test
0.6
13.1
145
2382
L16
ICPC
Ankle symptom/complaint
0.6
13.0
235
3431
J43.2
ICD-10 Finland
Centrilobular emphysema
4.7
13.0
44
87
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.7
13.0
588
7255
C34.94
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma
128.9
13.0
14
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
128.9
13.0
14
*
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
128.9
13.0
14
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.8
12.9
782
9261
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
0.5
12.9
84
1617
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
0.7
12.9
622
7604
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
2.7
12.9
88
302
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.0
12.9
75
234
UJC02
NOMESCO Finland
Rigid oesophagoscopy
3.0
12.8
75
235
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.2
12.7
66
190
N02AA03
ATC
hydromorphone; systemic, rectal
4.9
12.7
41
77
M02AA10
ATC
ketoprofen; topical
0.7
12.7
603
7394
A02BX02
ATC
sucralfate; oral
1.6
12.7
346
2041
DJB10
NOMESCO Finland
Excision of septum of nose
19.5
12.7
19
9
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
0.4
12.7
52
1181
N30.0
ICD-10 Finland
Acute cystitis
0.7
12.7
424
5494
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
0.6
12.6
152
2444
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.4
12.6
60
162
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
0.5
12.6
112
1958
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.7
12.6
506
6359
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
12.5
421
5449
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
12.5
445
5708
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
0.7
12.5
373
4932
L01
ICPC
Neck symptom/complaint
0.7
12.5
348
4654
F05.1
ICD-10 Finland
Delirium superimposed on dementia
0.1
12.4
*
348
Z01.0
ICD-10 Finland
Examination of eyes and vision
0.7
12.4
620
7544
WE198
NOMESCO Finland
Palliative cystotatic therapy
8.9
12.4
26
27
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
0.7
12.3
569
7003
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
0.4
12.3
66
1357
A29
ICPC
General symptom/complaint other
0.7
12.3
417
5390
GAC46
NOMESCO Finland
Partial decortication of pleura
6.9
12.3
30
40
SPAT1262
SPAT
Handing over of treatment supplies
0.8
12.2
906
10451
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.7
12.1
439
5612
GBA28
NOMESCO Finland
Endoscopic laser therapy of lesion of trachea
64.6
12.1
14
*
8249/3-C34.1
ICD-O-3
Neuroendocrine tumor, grade 2 of upper lobe, lung
+∞
12.1
12
*
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
12.1
12
*
1623D
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MACROCELLUL]
+∞
12.1
12
*
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
12.1
12
*
8550/3-C34.1
ICD-O-3
Acinar cell carcinoma of upper lobe, lung
+∞
12.1
12
*
S21
ICPC
Skin texture symptom/complaint
0.7
12.1
443
5651
R35
ICD-10 Finland
Polyuria
0.6
12.0
229
3305
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
3.6
12.0
53
135
SPAT1211
SPAT
Application of soft bandage
0.7
12.0
296
4051
Y85
ICPC
Benign prostatic hypertrophy
0.3
12.0
32
869
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
6.4
11.9
31
45
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
11.9
1693
18218
4040
NOMESCO Finland
NA
15.9
11.9
19
11
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
11.9
129
564
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
2.1
11.9
134
596
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.7
11.8
511
6348
S12
ICPC
Insect bite/sting
0.6
11.7
210
3070
I49.5
ICD-10 Finland
Sick sinus syndrome
0.6
11.7
132
2158
N07BC02
ATC
methadone; systemic
5.9
11.7
32
50
H29
ICPC
Ear symptom/complaint other
0.7
11.7
324
4335
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
0.5
11.6
84
1566
N03AX14
ATC
levetiracetam; systemic
1.9
11.6
162
779
Z00.8
ICD-10 Finland
Other general examinations
0.6
11.6
167
2568
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.6
11.6
293
1698
WW200
NOMESCO Finland
Immunization
1.9
11.6
162
782
ACC51
NOMESCO Finland
Release of median nerve
0.6
11.6
144
2296
K04.1
ICD-10 Finland
Necrosis of pulp
0.6
11.6
222
3199
JN4DD
NOMESCO Finland
Scout CT scan of torso
7.0
11.5
28
37
AAE99
NOMESCO Finland
Other operation by cranial base approach
24.6
11.5
16
6
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
0.6
11.5
185
2772
S01EE01
ATC
latanoprost; ophthalmic
0.6
11.5
247
3475
B35.1
ICD-10 Finland
Tinea unguium
0.5
11.5
115
1944
R50.9
ICD-10 Finland
Fever, unspecified
1.3
11.5
955
6941
XF404
NOMESCO Finland
Ambulatory ECG
0.7
11.5
357
4681
P06
ICPC
Sleep disturbance
0.6
11.5
204
2990
RS220
NOMESCO Finland
NA
2.6
11.4
83
296
R83
ICPC
Respiratory infection other
0.7
11.4
438
5546
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
0.4
11.4
42
997
C09CA03
ATC
valsartan; oral
0.7
11.4
330
4382
A10BH01
ATC
sitagliptin; oral
0.7
11.4
389
5020
L28
ICPC
Limited function/disability (L)
0.8
11.3
808
9373
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
0.6
11.3
226
3226
S22
ICPC
Nail symptom/complaint
0.6
11.3
141
2244
R01AD09
ATC
mometasone; nasal
0.8
11.3
1762
18802
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.4
11.3
51
1114
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
0.4
11.3
57
1197
H91.9
ICD-10 Finland
Hearing loss, unspecified
0.5
11.3
116
1943
Y06
ICPC
Prostate symptom/complaint
0.5
11.2
87
1586
TJD20
NOMESCO Finland
Change of gastrostomy tube
3.9
11.2
45
106
I20.09
ICD-10 Finland
Unstable angina
0.7
11.2
270
3716
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
4.7
11.2
37
72
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.7
11.2
327
4335
G04BD08
ATC
solifenacin; oral
0.6
11.2
233
3296
M09AX01
ATC
hyaluronic acid; parenteral
0.6
11.2
168
2558
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
0.7
11.2
313
4182
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.3
11.1
101
408
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
11.1
412
5249
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
11.1
11
*
C32.3
ICD-10 Finland
Malignant neoplasm: Laryngeal cartilage
+∞
11.1
11
*
C45
ICD-10 Finland
Mesothelioma
+∞
11.1
11
*
1623F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,MUU HISTOLOGIA]
+∞
11.1
11
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.1
11
*
8230/3-C34.1
ICD-O-3
Solid carcinoma, NOS, of upper lobe, lung
+∞
11.1
11
*
I44.1
ICD-10 Finland
Atrioventricular block, second degree
0.4
11.1
60
1231
H84
ICPC
Presbyacusis
0.5
11.1
101
1749
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
6.2
11.1
29
43
R92
ICPC
Neoplasm respiratory unspecified
21.1
11.0
16
7
H25.0
ICD-10 Finland
Senile incipient cataract
0.6
11.0
232
3280
GDD96
NOMESCO Finland
Other pneumonectomy
110.5
11.0
12
*
M02AA07
ATC
piroxicam; topical
0.8
11.0
1988
20950
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.6
11.0
246
3435
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.2
11.0
107
445
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
0.6
10.9
163
2487
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
0.7
10.9
254
3518
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
3.8
10.9
45
109
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
10.9
156
761
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
0.7
10.9
355
4618
N39.4
ICD-10 Finland
Other specified urinary incontinence
0.6
10.8
212
3039
J02AC02
ATC
itraconazole; systemic
0.8
10.8
604
7239
JN5AP
NOMESCO Finland
Total body PET (1 picture)
9.2
10.8
22
22
R07.4
ICD-10 Finland
Chest pain, unspecified
0.8
10.8
1380
15023
R03AC19
ATC
olodaterol; inhalant
3.8
10.8
45
110
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
32.2
10.8
14
*
SGC00
NOMESCO Finland
Local medication of root channels of tooth
0.6
10.8
203
2936
M76.6
ICD-10 Finland
Achilles tendinitis
0.5
10.8
72
1374
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.7
10.8
522
6381
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
0.5
10.8
75
1409
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
5.5
10.7
31
52
SPAT1100
SPAT
Long-term monitoring of blood pressure
0.7
10.7
281
3800
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
23.0
10.6
15
6
WX111
NOMESCO Finland
Local infiltration anesthesia
0.4
10.6
46
1021
N04BC05
ATC
pramipexole; oral
0.6
10.6
229
3218
A10BJ06
ATC
semaglutide; parenteral
0.4
10.6
32
823
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
11.7
10.5
19
15
C05AA08
ATC
fluocortolone; rectal, topical
0.7
10.5
531
6456
1XC18
NOMESCO Finland
NA
39.9
10.5
13
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
39.9
10.5
13
*
U04
ICPC
Incontinence urine
0.6
10.5
124
2001
R25.1
ICD-10 Finland
Tremor, unspecified
0.4
10.4
49
1054
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
6.0
10.4
28
43
EBA00
NOMESCO Finland
Extraction of tooth
0.8
10.4
1382
14996
D07AB02
ATC
hydrocortisone butyrate; topical
0.8
10.4
1270
13892
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
0.2
10.4
9
446
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.7
10.4
248
3416
U05
ICPC
Urination problems other
0.6
10.4
138
2162
K77
ICPC
Heart failure
0.4
10.4
44
983
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
0.7
10.3
429
5366
A02BC01
ATC
omeprazole; systemic
1.2
10.3
2051
16412
R82
ICPC
Pleurisy/pleural effusion
8.4
10.3
22
24
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.9
10.3
139
662
L14
ICPC
Leg/thigh symptom/complaint
0.6
10.3
209
2974
W19
ICD-10 Finland
Unspecified fall
0.7
10.3
341
4423
J01EA01
ATC
trimethoprim; systemic
0.8
10.3
1091
12109
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.6
10.3
121
1956
C34.07
ICD-10 Finland
Malignant tumor of the main bronchus carcinoid
55.2
10.2
12
*
J01CE02
ATC
phenoxymethylpenicillin; oral
0.9
10.2
3668
36677
L02AE02
ATC
leuprorelin; implant, parenteral
0.7
10.1
254
3468
R03BA02
ATC
budesonide; inhalant
1.3
10.1
1000
7424
GBA22
NOMESCO Finland
Endoscopic excision of lesion of trachea
+∞
10.1
10
*
9591/3-C34.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS
+∞
10.1
10
*
1628C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,ADENOCARCINOMA]
+∞
10.1
10
*
GE1CT
NOMESCO Finland
Mediastinal biopsy with CT guidance
+∞
10.1
10
*
1625G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,VAIN SYTOL DG]
+∞
10.1
10
*
8020/3-C34.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of upper lobe, lung
+∞
10.1
10
*
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
10.1
10
*
1625F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,MUU HISTOLOGIA]
+∞
10.1
10
*
8560/3-C34.1
ICD-O-3
Adenosquamous carcinoma of upper lobe, lung
+∞
10.1
10
*
8560/3-C34.3
ICD-O-3
Adenosquamous carcinoma of lower lobe, lung
+∞
10.1
10
*
8013/3-C34.3
ICD-O-3
Large cell neuroendocrine carcinoma of lower lobe, lung
+∞
10.1
10
*
8020/3-C34.3
ICD-O-3
Carcinoma, undifferentiated, NOS, of lower lobe, lung
+∞
10.1
10
*
K02.0
ICD-10 Finland
Caries limited to enamel
0.6
10.1
217
3047
OAB44
SPAT
NA
0.4
10.1
32
805
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.5
10.0
323
1987
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
5.0
10.0
31
57
SPAT1377
SPAT
Polysomnography
0.4
10.0
39
901
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.2
9.9
51
148
Z25.1
ICD-10 Finland
Need for immunization against influenza
0.6
9.9
133
2077
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
0.6
9.9
181
2634
C07AB02
ATC
metoprolol; systemic
0.8
9.8
1454
15626
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.5
9.8
86
1506
SAA03
NOMESCO Finland
Extended examination of mouth
0.8
9.8
1420
15292
R24
ICPC
Haemoptysis
2.9
9.8
58
185
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
0.4
9.8
52
1070
I34.1
ICD-10 Finland
Mitral (valve) prolapse
0.4
9.8
52
1072
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
0.5
9.8
55
1109
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.6
9.8
159
2374
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.8
9.8
728
8412
J98.4
ICD-10 Finland
Other disorders of lung
5.2
9.7
29
51
S15
ICPC
Foreign body in skin
0.6
9.7
158
2360
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
0.7
9.7
324
4201
XG466
NOMESCO Finland
Sleep oxymetry
1.6
9.7
218
1229
K03.00
ICD-10 Finland
Approximal wear
0.5
9.7
73
1339
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.6
9.7
147
2229
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
9.7
383
4825
EEB00
NOMESCO Finland
Partial excision of maxilla
8.8
9.6
20
21
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
8.8
9.6
20
21
K22
ICPC
Risk factor cardiovascular disease
0.6
9.6
161
2390
I35.0
ICD-10 Finland
Aortic (valve) stenosis
0.7
9.6
307
4008
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
12.0
9.6
17
13
GCA08
NOMESCO Finland
Bronchoscopic excsion of lesion of bronchus
12.0
9.6
17
13
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.2
9.6
95
399
N81.6
ICD-10 Finland
Rectocele
0.5
9.6
90
1545
AXX01
SPAT
NA
0.2
9.6
11
461
DQB20
NOMESCO Finland
Partial excision of larynx
36.8
9.6
12
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
0.8
9.6
759
8699
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
0.5
9.6
59
1155
TPX10
NOMESCO Finland
Implantation of vascular injection port
1.7
9.5
177
944
SPAT1058
SPAT
PEF monitoring instruction
0.7
9.5
239
3261
A69.2
ICD-10 Finland
Lyme disease
0.5
9.5
98
1641
XX9CD
NOMESCO Finland
Very extensive complementary CT
10.4
9.5
18
16
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.6
9.5
69
250
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.5
9.5
79
1404
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
5.0
9.4
29
53
F06.7
ICD-10 Finland
Mild cognitive disorder
0.5
9.4
71
1300
I50
ICD-10 Finland
Heart failure
0.6
9.4
115
1838
H3600, E113
ICD-10 Finland
NA
0.3
9.4
19
586
M10.0
ICD-10 Finland
Idiopathic gout
0.6
9.4
104
1708
A44
ICPC
General and Unspecified, Preventive immunization/medic
0.7
9.4
218
3017
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
0.6
9.4
144
2177
I20.01
ICD-10 Finland
Unstable angina
0.6
9.4
116
1846
D07AC01
ATC
betamethasone; topical
0.8
9.4
1730
18242
WX723
NOMESCO Finland
CPAP therapy
0.4
9.3
42
916
I48.2
ICD-10 Finland
Chronic atrial fibrillation
0.5
9.3
64
1204
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
3.9
9.3
37
88
I48.1
ICD-10 Finland
Persistent atrial fibrillation
0.5
9.3
60
1152
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
0.5
9.3
84
1456
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.6
9.3
222
1275
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.4
9.3
366
2354
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
7.0
9.2
22
29
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
0.6
9.2
176
2532
N05CD07
ATC
temazepam; oral
1.2
9.2
1082
8199
163
Kela drug reimbursment
Abiraterone and enzalutamide
0.3
9.2
15
513
S01EE05
ATC
tafluprost; ophthalmic
0.5
9.2
73
1317
C03AA03
ATC
hydrochlorothiazide; oral
0.7
9.2
459
5586
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
0.5
9.1
75
1338
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
0.7
9.1
461
5602
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
5.8
9.1
25
40
1243
FHL
Bronchoscopy and other therapeutic procedure
5.8
9.1
25
40
TDA90
SPAT
NA
0.4
9.1
32
769
C33.99
ICD-10 Finland
Malignant tumor of the trachea other or unspecified histology
92.1
9.1
10
*
L01EB02
ATC
erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
+∞
9.1
9
*
8072/3-C34.3
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung
+∞
9.1
9
*
8550/3-C34.3
ICD-O-3
Acinar cell carcinoma of lower lobe, lung
+∞
9.1
9
*
8070/3-C33.9
ICD-O-3
Squamous cell carcinoma, NOS, of trachea
+∞
9.1
9
*
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
+∞
9.1
9
*
K76
ICPC
Ischaemic heart dis without angina
0.5
9.1
67
1234
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
5.4
9.1
26
44
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1.9
9.1
129
629
S04
ICPC
Lump/swelling localized
0.7
9.1
250
3351
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
13.8
9.0
15
10
GAC36
NOMESCO Finland
Chemical pleurodesis
13.8
9.0
15
10
ZXB10
NOMESCO Finland
Medial
2.9
9.0
53
169
M48.0
ICD-10 Finland
Spinal stenosis
0.8
9.0
577
6794
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
27.6
9.0
12
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.6
9.0
166
2407
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
5.6
9.0
25
41
M01AB05
ATC
diclofenac; systemic, rectal
0.9
9.0
3657
36374
W00
ICD-10 Finland
Fall on same level involving ice and snow
0.7
8.9
336
4267
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
0.6
8.9
104
1685
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
2.8
8.9
56
184
J95.0
ICD-10 Finland
Tracheostomy malfunction
20.0
8.9
13
6
R49.0
ICD-10 Finland
Dysphonia
2.2
8.9
90
384
GAC43
NOMESCO Finland
Total decortication of pleura
11.3
8.9
16
13
XGX10
NOMESCO Finland
Intrapleural ultrasonography
11.3
8.9
16
13
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.8
8.8
695
7976
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.8
1571
12427
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
0.4
8.8
39
855
R05FB02
ATC
cough suppressants and expectorants
1.2
8.8
2666
22045
S01EC04
ATC
brinzolamide; ophthalmic
0.6
8.8
111
1760
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
2.7
8.8
58
200
N04BD02
ATC
rasagiline; oral
0.1
8.8
*
259
L11
ICPC
Wrist symptom/complaint
0.6
8.7
150
2209
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
8.7
8.7
18
19
S06.0
ICD-10 Finland
Concussion
0.7
8.7
329
4173
SPAT1285
SPAT
Provision of consultation response
0.6
8.7
149
2197
I25
ICD-10 Finland
Chronic ischaemic heart disease
0.7
8.7
212
2905
R81
ICPC
Pneumonia
1.6
8.7
217
1258
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
33.8
8.7
11
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
33.8
8.7
11
*
D01AE15
ATC
terbinafine; topical
0.7
8.6
257
3396
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
0.5
8.6
48
972
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
4.9
8.6
27
51
R4135
NOMESCO Finland
Rehabilitation for hearing problems
0.4
8.6
41
875
R01AD01
ATC
beclometasone; nasal
0.8
8.6
487
5824
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.5
8.5
298
1872
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
0.3
8.5
17
525
C02AC05
ATC
moxonidine; oral
0.6
8.5
143
2115
D15.2
ICD-10 Finland
Benign neoplasm: Mediastinum
17.1
8.5
13
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.4
8.5
69
266
R03AC18
ATC
indacaterol; inhalant
2.2
8.5
80
331
WZC30
SPAT
NA
0.3
8.5
19
555
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
0.6
8.4
123
1884
XCK00
NOMESCO Finland
Perimetry
0.7
8.4
240
3193
K05.31
ICD-10 Finland
Periodontitis pronounced
1.3
8.4
581
4113
J01DA06
ATC
[U] cefuroxime; systemic
1.3
8.4
839
6237
K05.1
ICD-10 Finland
Chronic gingivitis
0.6
8.4
119
1831
1628X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,EI HIST/SYTOL DG]
46.0
8.3
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
8.3
39
838
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
6.8
8.3
20
27
A02BA04
ATC
nizatidine; systemic
1.3
8.3
591
4200
SPAT1360
SPAT
Extensive global examination
0.7
8.3
264
3444
R06.5
ICD-10 Finland
Mouth breathing
0.7
8.3
228
3053
J98.1
ICD-10 Finland
Pulmonary collapse
2.6
8.3
60
216
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
8.3
482
5745
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
4.2
8.3
30
66
GAA97
NOMESCO Finland
Other thoracoscopic drainage procedures on pleura
8.7
8.2
17
18
G30
ICD-10 Finland
Alzheimer disease
0.3
8.2
23
611
GAC30
NOMESCO Finland
Artificial pneumothorax
12.9
8.2
14
10
TKE00
NOMESCO Finland
Needle biopsy of prostate
0.7
8.2
257
3369
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
0.6
8.2
120
1835
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
0.7
8.2
290
3723
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
0.5
8.2
49
968
SPAT1079
SPAT
Echocardiography
0.3
8.2
12
435
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
0.6
8.2
166
2362
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.7
8.2
179
2504
Z71.8
ICD-10 Finland
Other specified counselling
0.8
8.2
838
9347
C02EA02
ATC
NA
0.7
8.2
250
3289
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
0.6
8.2
177
2483
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
1.9
8.2
122
608
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
0.7
8.2
207
2813
N30.9
ICD-10 Finland
Cystitis, unspecified
0.6
8.2
137
2026
OAB43
SPAT
NA
0.6
8.2
104
1642
N19
ICD-10 Finland
Unspecified kidney failure
0.6
8.1
131
1959
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.4
8.1
380
2524
SPAT1016
SPAT
Examination of vision
0.6
8.1
127
1912
XQ848
NOMESCO Finland
Dermatological photography
0.5
8.1
49
962
8070/2-C34.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of lung, NOS
82.9
8.1
9
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
0.5
8.1
83
1389
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
0.7
8.1
213
2875
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
18.4
8.1
12
6
C38.0
ICD-10 Finland
Malignant neoplasm: Heart
+∞
8.1
8
*
8260/3-C34.1
ICD-O-3
Papillary adenocarcinoma, NOS, of upper lobe, lung
+∞
8.1
8
*
8012/3-C34.9
ICD-O-3
Large cell carcinoma, NOS, of lung, NOS
+∞
8.1
8
*
8260/3-C34.3
ICD-O-3
Papillary adenocarcinoma, NOS, of lower lobe, lung
+∞
8.1
8
*
L01ED01
ATC
crizotinib; oral
+∞
8.1
8
*
8000/3-C38.3
ICD-O-3
Neoplasm, malignant of mediastinum, NOS
+∞
8.1
8
*
GCA40
NOMESCO Finland
Closure of bronchopleural fistula
+∞
8.1
8
*
8071/3-C34.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung
+∞
8.1
8
*
M79.1
ICD-10 Finland
Myalgia
0.7
8.1
331
4147
L03.0
ICD-10 Finland
Cellulitis of finger and toe
0.7
8.0
177
2474
SPAT1324
SPAT
Screening procedure
0.7
8.0
177
2474
S06
ICPC
Rash localized
0.6
8.0
143
2090
L86
ICPC
Back syndrome with radiating pain
0.6
8.0
119
1810
R01AD08
ATC
fluticasone; nasal
0.8
8.0
1045
11381
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.7
8.0
228
3034
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
8.2
8.0
17
19
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
0.6
8.0
151
2178
WZC00
SPAT
NA
0.5
8.0
59
1088
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
0.4
8.0
38
809
ZXH06
SPAT
NA
0.4
8.0
26
645
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
0.3
8.0
14
460
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.5
8.0
82
1370
L30.9
ICD-10 Finland
Dermatitis, unspecified
0.8
8.0
644
7369
UJC12
NOMESCO Finland
Flexible oesophagoscopy
2.6
7.9
58
210
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
0.6
7.9
107
1666
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.6
7.9
182
1037
A01AB09
ATC
miconazole; local oral
1.3
7.9
541
3824
-31
ICPC
Medical examin/health eval partial
0.7
7.9
239
3147
XX1AD
NOMESCO Finland
Other CT-examination
3.0
7.9
43
132
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
7.9
425
2892
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
0.7
7.9
213
2863
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.2
7.9
1139
8821
TQW40
SPAT
NA
0.5
7.9
51
979
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
2.6
7.8
54
190
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
0.7
7.8
236
3110
N05BA01
ATC
diazepam; systemic, rectal
1.3
7.8
828
6198
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
9.9
7.8
15
14
ZX100
NOMESCO Finland
Oral
1.9
7.8
103
492
H43.8
ICD-10 Finland
Other disorders of vitreous body
0.7
7.8
257
3333
GDA20
NOMESCO Finland
Excision of lesion of lung
5.2
7.8
23
41
E83.50
ICD-10 Finland
Hypercalcemia
2.1
7.8
80
346
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
0.6
7.8
103
1609
R86
ICPC
Benign neoplasm respiratory
30.7
7.8
10
*
C38.2
ICD-10 Finland
Malignant neoplasm: Posterior mediastinum
30.7
7.8
10
*
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
30.7
7.8
10
*
A10BH05
ATC
linagliptin; oral
0.7
7.7
183
2518
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.0
7.7
42
129
R02
ICPC
Shortness of breath/dyspnoea
1.3
7.7
739
5462
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
7.7
485
3384
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
0.8
7.7
415
4997
E66.01
ICD-10 Finland
Obesity due to excess calories
0.6
7.7
121
1816
WX707
NOMESCO Finland
Fiberoscopic intubation
3.9
7.7
30
71
DQW99
NOMESCO Finland
Other operation on larynx
15.8
7.7
12
7
R53
ICD-10 Finland
Malaise and fatigue
0.8
7.7
1019
11082
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
0.5
7.7
52
982
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.6
7.7
99
1560
N04BC04
ATC
ropinirole; oral
0.2
7.7
8
351
A11
ICPC
Chest pain NOS
0.7
7.7
247
3218
K05
ICPC
Irregular heartbeat other
0.5
7.7
69
1194
SPAT1252
SPAT
Overall medication plan or its review
0.7
7.7
291
3687
EEB10
NOMESCO Finland
Maxillectomy
20.3
7.7
11
5
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
3.0
7.6
41
125
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
10.7
7.6
14
12
D06BX02
ATC
ingenol mebutate; topical
0.4
7.6
23
587
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
3.3
7.6
36
100
J01DA01
ATC
[U] cefalexin; systemic
1.1
7.6
4382
37762
ZXC15
NOMESCO Finland
Use of photodynamic technique
0.4
7.6
25
616
G04BE03
ATC
sildenafil; oral
0.4
7.6
25
616
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
0.4
7.6
24
603
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
0.6
7.6
154
2189
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.2
7.6
74
313
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
0.7
7.6
175
2420
I50.1
ICD-10 Finland
Left ventricular failure
0.7
7.6
265
3402
R5120
NOMESCO Finland
Preparation of an aid
0.5
7.6
74
1251
XX9XW
NOMESCO Finland
NA
2.7
7.5
48
162
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
6.3
7.5
19
28
I95.1
ICD-10 Finland
Orthostatic hypotension
0.6
7.5
136
1978
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
2.0
7.5
96
454
S97
ICPC
Chronic ulcer skin
0.7
7.5
204
2736
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.5
7.5
245
1519
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
2.5
7.5
53
192
A10AE04
ATC
insulin glargine; parenteral
0.8
7.5
393
4746
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
0.1
7.4
*
271
U06
ICPC
Haematuria
0.5
7.4
63
1109
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
2.1
7.4
82
364
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.5
7.4
57
1034
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
0.8
7.4
429
5116
1242
FHL
Bronchoscopy and transbronchial lung apia
5.8
7.4
20
32
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
0.5
7.4
43
856
L02BB04
ATC
enzalutamide; oral
0.3
7.4
11
398
GBA53
NOMESCO Finland
Prosthetic repair of trachea
41.4
7.4
9
*
GBA32
NOMESCO Finland
Endoscopic dilatation of trachea
41.4
7.4
9
*
D38
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
41.4
7.4
9
*
GEW99
NOMESCO Finland
Other operation on mediastinum
41.4
7.4
9
*
G04BD09
ATC
trospium; oral
0.5
7.4
50
946
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
0.5
7.4
70
1198
N05AH04
ATC
quetiapine; oral
0.8
7.4
516
6010
193
Kela drug reimbursment
Rasagiline
0.0
7.4
*
203
KED52
NOMESCO Finland
Visual laser resection of prostate
0.4
7.4
36
759
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
4.0
7.4
28
65
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
0.7
7.4
189
2564
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
0.7
7.4
165
2296
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.6
7.4
161
904
KGH10
NOMESCO Finland
Operation for phimosis
0.5
7.3
63
1105
WX780
NOMESCO Finland
Remote monitoring CPAP
0.5
7.3
54
991
M05BA02
ATC
clodronic acid; systemic
2.6
7.3
49
172
R55
ICD-10 Finland
Syncope and collapse
0.8
7.3
547
6318
I44.2
ICD-10 Finland
Atrioventricular block, complete
0.6
7.3
104
1597
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
0.5
7.3
42
838
R41.3
ICD-10 Finland
Other amnesia
0.6
7.3
81
1324
R44
ICPC
Respiratory, Preventive immunization/medic
0.4
7.3
29
659
S01.0
ICD-10 Finland
Open wound of scalp
0.7
7.3
296
3713
N81.1
ICD-10 Finland
Cystocele
0.6
7.3
105
1605
B01AC04
ATC
clopidogrel; oral
0.8
7.3
1044
11275
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
0.4
7.3
23
574
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
0.4
7.3
24
588
H36.00
ICD-10 Finland
Diabetic background retinopathy
0.3
7.3
15
455
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
6.4
7.2
18
26
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
0.7
7.2
310
3855
TFP20
NOMESCO Finland
Cardiodefibrillation
0.7
7.2
353
4305
CKC12
NOMESCO Finland
Photocoagulation of retina
0.6
7.2
94
1473
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
2.9
7.2
42
135
R01BA52
ATC
pseudoephedrine, combinations; oral
0.8
7.2
1144
12244
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
0.7
7.2
221
2897
SPAT1370
SPAT
Other health check-up
0.6
7.2
89
1411
XF640
NOMESCO Finland
NA
0.6
7.2
89
1415
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
7.2
390
2666
M15
ICD-10 Finland
Polyarthrosis
0.6
7.2
112
1680
C33.91
ICD-10 Finland
Malignant tumor of tracheal epidermoid carcinoma
73.7
7.2
8
*
16212
ICD-8 Finland
Malignant neoplasm of trachea, bronchus and lung, Lobi superioris pulmonis
73.7
7.2
8
*
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
73.7
7.2
8
*
D01
ICPC
Abdominal pain/cramps general
0.7
7.1
252
3230
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
4.3
7.1
25
54
N18.8
ICD-10 Finland
Other chronic renal failure
0.6
7.1
92
1446
J18
ICD-10 Finland
Pneumonia, organism unspecified
2.4
7.1
57
220
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
1.8
7.1
119
620
SPAT1236
SPAT
Informing family of child’s disability
0.4
7.1
34
724
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
7.4
7.1
16
20
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
0.4
7.1
33
707
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
4.4
7.1
24
50
XF402
NOMESCO Finland
ECG with work load test
0.8
7.1
488
5695
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
5.1
7.1
21
38
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
1.9
7.1
93
446
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
2.1
7.1
78
350
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.8
7.1
965
10471
1629E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA ALIA DEF/NUD]
+∞
7.1
7
*
8581/3-C37.9
ICD-O-3
Thymoma, type A of thymus
+∞
7.1
7
*
8010/3-C34.2
ICD-O-3
Carcinoma, NOS, of middle lobe, lung
+∞
7.1
7
*
8022/3-C34.3
ICD-O-3
Pleomorphic carcinoma of lower lobe, lung
+∞
7.1
7
*
1628E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA ALIA DEF/NUD]
+∞
7.1
7
*
3017
Kela drug reimbursment
Brigatinib
+∞
7.1
7
*
8046/3-C34.0
ICD-O-3
Non-small cell carcinoma of main bronchus
+∞
7.1
7
*
C79.49
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified parts of nervous system
+∞
7.1
7
*
8230/3-C34.3
ICD-O-3
Solid carcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
8583/3-C37.9
ICD-O-3
Thymoma, type B1 of thymus
+∞
7.1
7
*
8012/3-C34.3
ICD-O-3
Large cell carcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
1629G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,VAIN SYTOL DG]
+∞
7.1
7
*
8072/3-C34.1
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung
+∞
7.1
7
*
GDC23
NOMESCO Finland
Lobectomy and segment resection of lung
+∞
7.1
7
*
8585/3-C37.9
ICD-O-3
Thymoma, type B3 of thymus
+∞
7.1
7
*
G03CA04
ATC
estriol; systemic, vaginal
0.7
7.0
153
2140
H11.3
ICD-10 Finland
Conjunctival haemorrhage
0.6
7.0
98
1510
Z01.7
ICD-10 Finland
Laboratory examination
0.7
7.0
350
4262
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
3.4
7.0
32
87
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.7
7.0
45
152
S27.0
ICD-10 Finland
Traumatic pneumothorax
2.3
7.0
62
251
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
3.3
7.0
33
92
S08
ICPC
Skin colour change
0.6
7.0
134
1925
M13.9
ICD-10 Finland
Arthritis, unspecified
0.7
7.0
198
2638
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
0.5
7.0
56
1005
G03AC03
ATC
levonorgestrel; systemic
0.6
7.0
128
1853
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
2.9
7.0
40
126
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
5.0
6.9
21
39
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
5.0
6.9
21
39
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
0.8
6.9
748
8303
A10BX01
ATC
guar gum; systemic
0.6
6.9
147
2066
C09DA03
ATC
valsartan and diuretics; oral
0.6
6.9
147
2068
U71
ICPC
Cystitis/urinary infection other
0.6
6.9
110
1642
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
0.5
6.9
53
960
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
0.5
6.9
53
960
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
0.7
6.9
245
3138
A46
ICD-10 Finland
Erysipelas
0.8
6.9
717
7984
Z85.1
ICD-10 Finland
Personal history of malignant neoplasm of trachea, bronchus and lung
14.5
6.9
11
7
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
2.3
6.9
61
248
K07
ICPC
Swollen ankles/oedema
0.6
6.9
139
1973
C03DA01
ATC
spironolactone; oral
0.8
6.8
562
6424
R06AX27
ATC
desloratadine; oral
0.8
6.8
736
8168
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
3.5
6.8
30
80
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
0.7
6.8
182
2447
SPAT1251
SPAT
Organisation of medication
0.6
6.8
125
1808
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
1.8
6.8
106
539
C09BA02
ATC
enalapril and diuretics; systemic
0.8
6.8
434
5106
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
0.5
6.8
38
763
M03BX02
ATC
tizanidine; oral
0.9
6.8
2842
28387
B01AE07
ATC
dabigatran etexilate; oral
0.6
6.8
128
1843
P17
ICPC
Tobacco abuse
2.2
6.7
62
256
SPAT1167
SPAT
Insertion of urinary catheter
0.6
6.7
138
1947
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
0.1
6.7
*
249
NG2AA
NOMESCO Finland
Patella X-ray examination
0.5
6.7
46
864
M10
ICD-10 Finland
Gout
0.7
6.7
154
2127
T93
ICPC
Lipid disorder
0.7
6.6
157
2160
K08.80
ICD-10 Finland
Toothache NOS
0.6
6.6
128
1831
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.7
6.6
121
647
M65.3
ICD-10 Finland
Trigger finger
0.6
6.6
75
1218
FN2CA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure
0.3
6.6
16
447
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
0.7
6.6
195
2572
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
5.5
6.6
18
30
M53.0
ICD-10 Finland
Cervicocranial syndrome
0.7
6.5
164
2228
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
0.6
6.5
92
1416
K40
ICD-10 Finland
Inguinal hernia
0.5
6.5
59
1019
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
0.8
6.5
394
4670
4503
FHL
Partial laryngeal removal
36.8
6.5
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
0.8
6.5
1011
10845
S09
ICPC
Infected finger/toe
0.5
6.5
52
930
K29
ICPC
Cardiovascular sympt/complt other
0.6
6.4
138
1937
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
3.5
6.4
28
74
F29
ICPC
Eye symptom/complaint other
0.7
6.4
223
2863
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
2.8
6.4
39
130
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
0.3
6.4
16
444
C09CA07
ATC
telmisartan; oral
0.7
6.4
241
3055
TGA10
NOMESCO Finland
Needle biopsy of pleura
5.3
6.4
18
31
N18.0
ICD-10 Finland
End-stage renal disease
0.4
6.4
21
514
ZXA10
NOMESCO Finland
Bilateral
0.8
6.4
936
10098
C07AB07
ATC
bisoprolol; oral
0.9
6.4
3510
34543
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
0.4
6.4
30
641
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
2.4
6.4
52
204
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
0.8
6.4
388
4595
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
6.4
460
5334
J30.0
ICD-10 Finland
Vasomotor rhinitis
0.5
6.3
42
795
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
0.7
6.3
158
2148
E66.8
ICD-10 Finland
Other obesity
0.5
6.3
64
1072
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
0.4
6.3
28
613
81
HP
Angiography of the heart and coronary arteries
0.8
6.3
458
5311
N05AB01
ATC
dixyrazine; systemic
2.0
6.3
79
374
C10AA04
ATC
fluvastatin; oral
0.8
6.3
469
5423
C07AG02
ATC
carvedilol; oral
0.7
6.3
280
3460
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
0.7
6.3
171
2291
SPAT1229
SPAT
Assessment of need for aid
0.8
6.3
354
4237
WYA20
NOMESCO Finland
Home visit
0.5
6.3
40
768
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
0.6
6.3
92
1401
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
0.6
6.3
119
1708
B03BA03
ATC
hydroxocobalamin; parenteral
1.3
6.3
482
3468
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
0.6
6.3
69
1129
KDV10
NOMESCO Finland
Internal urethrotomy
0.5
6.3
39
752
Z31.6
ICD-10 Finland
General counselling and advice on procreation
6.6
6.3
15
21
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
0.4
6.3
30
636
L29
ICPC
Musculoskeletal sympt/complt other
0.7
6.2
220
2819
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
2.3
6.2
52
207
SPAT1202
SPAT
Intra-articular injection
0.6
6.2
79
1247
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
0.4
6.2
29
623
R02AD02
ATC
lidocaine; local oral
1.9
6.2
80
382
M04AA01
ATC
allopurinol; systemic
0.8
6.2
900
9720
WVA30
SPAT
NA
0.5
6.2
41
777
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
0.6
6.2
72
1161
5821
FHL
Needle biopsy in the operating room
64.5
6.2
7
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
64.5
6.2
7
*
C09DA06
ATC
candesartan and diuretics; oral
0.7
6.2
248
3112
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
0.4
6.2
32
661
1430
FHL
Laryngoscopy (direct)
4.1
6.2
22
49
M01AH01
ATC
celecoxib; oral (coxibs)
0.8
6.2
773
8458
K04.0
ICD-10 Finland
Pulpitis
0.7
6.2
146
2004
EBA05
NOMESCO Finland
Complicated extraction of tooth
0.8
6.2
649
7221
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
8.0
6.2
13
15
R06AX22
ATC
ebastine; oral
0.8
6.1
478
5493
C01BC04
ATC
flecainide; systemic
0.6
6.1
100
1485
H40.11
ICD-10 Finland
Low pressure glaucoma
0.5
6.1
42
788
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.2
6.1
59
251
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
5.4
6.1
17
29
K84
ICPC
Heart disease other
0.6
6.1
72
1156
C10AA03
ATC
pravastatin; oral
0.8
6.1
340
4072
KE1BG
NOMESCO Finland
MRI of prostate
0.2
6.1
6
270
SGC10
NOMESCO Finland
Covering pulpa of tooth
0.7
6.1
138
1913
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.6
6.1
104
1526
GBB18
NOMESCO Finland
Closure of tracheostomy
13.2
6.1
10
7
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.6
6.1
40
140
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
6.1
6
*
8551/3-C34.9
ICD-O-3
Acinar cell cystadenocarcinoma of lung, NOS
+∞
6.1
6
*
8000/3-C39.9
ICD-O-3
Neoplasm, malignant of ill-defined sites within respiratory system
+∞
6.1
6
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.1
6
*
8246/3-C34.3
ICD-O-3
Neuroendocrine carcinoma, NOS, of lower lobe, lung
+∞
6.1
6
*
8070/3-C37.9
ICD-O-3
Squamous cell carcinoma, NOS, of thymus
+∞
6.1
6
*
C33.90
ICD-10 Finland
Malignant tumor of the trachea without histology
+∞
6.1
6
*
C34.24
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung macrocellular anaplastic carcinoma
+∞
6.1
6
*
8022/3-C34.1
ICD-O-3
Pleomorphic carcinoma of upper lobe, lung
+∞
6.1
6
*
3026
Kela drug reimbursment
Lorlatinib
+∞
6.1
6
*
8000/3-C34.8
ICD-O-3
Neoplasm, malignant of overlapping lesion of lung
+∞
6.1
6
*
1638X
ICD-9 Finland
Malignant neoplasm of pleura, Other specified sites of pleura
+∞
6.1
6
*
M54.2
ICD-10 Finland
Cervicalgia
0.7
6.0
159
2140
D11
ICPC
Diarrhoea
0.7
6.0
239
3003
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
0.4
6.0
22
518
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
0.6
6.0
88
1338
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
0.6
6.0
76
1198
J38.4
ICD-10 Finland
Oedema of larynx
3.0
6.0
32
99

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003434) Protein [Mass/volume] in Pleural fluid
705
1330
5.18
316.00
1.5
1.5
g/l
38.7
29.9
57.87
659
1171
(3042631) Mycobacterium sp identified in Specimen
640
1124
5.54
310.32
1.9
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4123
58532
0.38
307.65
3.7
4.7
mmol/l
1.4
1.4
4.09
3508
52239
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4563
60274
0.42
307.65
4.7
5.1
mmol/l
6.2
6.1
1.13
3942
53258
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4404
60945
0.38
307.65
4.1
5.4
mmol/l
2.6
2.5
3.85
3737
54596
(3024731) MCV [Entitic volume]
5493
67149
0.42
307.65
41.0
26.0
fl
91.6
91.8
3.91
5366
65642
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4044
56684
0.41
307.65
3.4
4.3
mmol/l
1.3
1.3
4.84
3411
50102
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1244
2801
4.55
307.65
2.2
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4202
59153
0.38
307.65
3.7
4.8
mmol/l
4.4
4.4
3.09
3632
53249
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4105
58069
0.39
307.65
5.5
6.7
mmol/mol
41.3
41.2
0.20
3574
52369
(3035941) MCH [Entitic mass]
5492
67150
0.42
307.65
41.0
26.0
pg
30.1
30.5
38.52
5364
65640
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
272
10
257.53
307.65
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
639
994
6.27
307.65
1.7
1.5
—
—
—
0
0
(4035726)
2551
5424
5.53
307.65
1.5
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
5492
67154
0.42
307.65
41.1
26.1
e12/l
4.2
4.4
102.82
5284
64529
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
1132
858
13.63
307.65
2.2
1.7
ug/l
30.8
20.2
4.21
1115
836
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1223
1642
7.71
307.65
1.4
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
1185
786
15.68
307.65
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
5493
67135
0.42
307.65
41.2
26.1
e9/l
269.3
235.2
163.96
5310
64823
(3000963) Hemoglobin [Mass/volume] in Blood
5493
67162
0.42
307.65
41.4
26.3
g/l
125.7
133.0
210.65
5372
65641
(3010813) Leukocytes [#/volume] in Blood
5496
67169
0.42
307.65
41.2
26.1
e9/l
8.0
7.0
63.80
5283
64578
(3023199) Leukocytes [#/volume] in Pleural fluid
643
1145
5.47
307.09
1.5
1.5
e6/l
2586.4
2321.8
0.23
506
814
(3028308) Erythrocytes [#/volume] in Pleural fluid
606
1038
5.67
301.65
1.5
1.5
e6/l
61735.6
67385.6
0.13
418
605
(3023103) Potassium [Moles/volume] in Serum or Plasma
5468
65769
0.45
290.76
31.7
21.5
mmol/l
4.0
4.0
0.10
5305
63726
(3012441) Differential panel - Pleural fluid
584
1001
5.65
290.34
1.5
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
689
1370
4.91
290.22
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5372
64977
0.46
288.39
18.1
11.1
u/l
25.3
25.2
0.05
5239
61812
(3019550) Sodium [Moles/volume] in Serum or Plasma
5469
65672
0.46
286.17
31.6
21.3
mmol/l
138.3
139.6
163.54
5322
63731
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2542
11507
2.40
278.26
4.7
3.0
mmol/l
0.8
0.8
40.35
2453
10565
(3035637) Corticotropin [Mass/volume] in Plasma
449
649
6.63
264.47
1.7
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1932
7958
2.54
257.23
3.3
3.9
ug/l
58.6
21.1
2.79
1740
6582
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
453
699
6.21
250.38
1.3
1.3
u/l
13.3
13.8
0.15
440
631
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4361
55776
0.49
249.95
5.3
4.5
mu/l
2.0
2.2
1.05
3833
49362
(40761511) CBC panel - Blood by Automated count
5244
62993
0.49
248.55
25.4
17.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
506
891
5.46
243.87
1.3
1.3
u/l
724.0
382.9
1.61
496
836
(3036782) Glucose [Moles/volume] in Pleural fluid
481
866
5.33
226.07
1.4
1.4
mmol/l
5.6
6.5
6.80
453
796
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2211
35129
0.45
224.56
4.2
5.5
ug/l
2.6
4.9
9.99
1868
30842
(3045788) Cell count panel - Pleural fluid
482
879
5.26
223.32
1.5
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4743
57706
0.52
207.26
28.4
17.1
ml/min/173m2
77.7
71.8
72.85
4267
47869
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
380
651
5.55
188.20
1.4
1.4
u/l
10.7
13.9
17.89
368
621
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1670
27991
0.45
183.22
3.8
4.8
%
20.9
22.3
3.45
786
15131
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5459
62311
0.55
165.92
31.1
17.9
mg/l
37.7
28.3
66.95
5171
51463
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
735
16015
0.37
146.80
1.6
1.6
mmol/l
1.4
1.3
2.25
628
13112
(3035880) pH of Pleural fluid
298
520
5.41
144.49
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2147
31253
0.53
143.04
1.9
2.1
pmol/l
87.7
91.8
4.13
1139
16780
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1186
5114
2.29
135.86
5.2
2.1
nmol/l
425.8
370.7
12.26
1139
4610
(3020682) Albumin/Creatinine [Ratio] in Urine
1462
23654
0.49
132.82
3.6
4.0
mg/mmol
12.8
10.1
1.01
897
15226
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3609
44731
0.59
129.22
4.7
3.7
pmol/l
15.1
15.1
0.67
3237
39344
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1809
9352
1.96
128.22
4.2
3.9
u/l
253.5
247.7
0.64
1751
8700
(3009508) Creatinine [Moles/volume] in Urine
1382
22579
0.49
128.14
2.8
3.2
mmol/l
7.3
7.4
0.47
1071
18419
(3012516) Albumin [Mass/volume] in Urine
1364
22304
0.49
126.38
2.9
3.3
mg/l
494.6
350.9
0.52
885
14553
(3003338) MCHC [Mass/volume]
4076
48592
0.60
120.35
38.0
23.6
g/l
328.5
331.6
78.51
4005
47950
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1161
19672
0.48
117.56
2.8
3.3
ug/l
0.8
0.9
0.34
803
14281
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
292
603
4.56
116.44
1.3
1.3
—
—
—
0
0
(4010399)
1033
4506
2.24
114.07
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4601
52976
0.61
113.76
31.0
19.2
%
37.7
38.4
5.25
2950
31971
(3009261) Glucose [Presence] in Urine by Test strip
2373
32127
0.57
113.14
3.5
4.0
estimate
0.0
0.0
1.60
527
5834
(3021601) Nitrite [Presence] in Urine by Test strip
2333
31693
0.57
112.42
4.7
5.2
estimate
0.0
0.0
0.50
548
6022
(3035350) Ketones [Presence] in Urine by Test strip
2341
31716
0.58
111.27
3.5
3.9
estimate
0.0
0.0
0.50
545
5963
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
189
287
6.16
105.75
1.3
1.3
ug/l
366.2
346.1
0.04
133
140
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1787
25774
0.56
105.03
2.0
2.2
nmol/l
75.0
78.9
6.72
1536
22267
(3009214) Lutropin [Units/volume] in Serum or Plasma
345
900
3.62
100.30
1.4
1.3
u/l
13.0
10.7
1.83
284
709
(1761868) Lipid panel - Serum or Plasma
990
16856
0.49
98.31
3.0
3.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3398
22470
1.61
97.19
6.5
5.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3900
45699
0.64
94.04
4.2
4.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4265
48766
0.65
89.18
36.4
21.7
%
14.5
14.0
102.05
4193
47452
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1737
24403
0.58
88.57
3.9
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
3923
45470
0.65
85.88
4.6
4.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
169
292
5.40
82.77
1.3
1.3
mmol/l
3.5
3.6
0.10
160
258
(3021960) Folate [Moles/volume] in Serum or Plasma
1211
18501
0.54
82.40
1.5
1.6
nmol/l
19.3
19.7
0.52
1066
15666
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
298
822
3.41
79.53
3.0
3.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1944
11748
1.66
76.75
2.1
1.9
s
29.9
30.3
2.90
1909
11382
(3022096) Basophils/100 leukocytes in Blood
4034
29079
1.48
70.80
6.9
5.7
%
0.6
0.6
8.16
3910
26668
(3023419) Bacteria identified in Sputum by Culture
316
973
3.06
70.42
1.7
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2012
26105
0.63
69.08
2.5
2.9
ug/l
251.5
164.9
14.14
1818
23385
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1094
16426
0.56
67.57
1.6
1.8
pmol/l
12457595.0
25854633.0
0.51
875
13170
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
177
379
4.36
67.46
1.4
1.4
%
66.5
67.0
0.07
152
298
(3001893) Eosinophils/100 leukocytes in Pleural fluid
162
323
4.68
67.43
1.3
1.4
%
4.3
2.3
1.54
146
262
(3018418) pH of Serum or Plasma
3064
21204
1.48
64.36
5.5
4.0
ph
7.4
7.4
1.13
574
4081
(3019069) Monocytes/100 leukocytes in Blood
4102
30035
1.45
64.27
7.1
6.0
%
9.1
9.0
1.13
3973
27596
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
148
285
4.84
64.21
1.4
1.4
u/l
26.3
31.7
1.08
140
227
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
855
4271
1.92
63.97
8.5
7.9
mmol/l
24.9
24.1
12.13
823
3885
(3006504) Eosinophils/100 leukocytes in Blood
4078
29892
1.44
63.14
6.9
5.7
%
2.4
2.9
39.14
3948
27378
(3023368) Bacteria identified in Blood by Culture
3250
22840
1.47
62.74
5.0
4.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
942
14441
0.56
61.86
3.9
4.4
kg/l
1.0
1.0
0.06
160
2245
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2333
28812
0.66
61.15
2.6
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1671
10262
1.60
60.07
2.0
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4125
30556
1.42
58.87
7.0
5.9
%
21.7
25.6
92.13
3987
27870
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
852
4389
1.86
57.78
7.0
6.5
mmol/l
25.6
24.6
13.89
843
4338
(3031040) Bacteria [#/volume] in Urine by Automated count
4087
45201
0.71
56.76
4.4
4.9
e6/l
536.1
1198.5
0.96
83
868
(3033658) Prothrombin time (PT) actual/Normal
2502
16964
1.48
56.71
5.6
4.1
%
90.4
82.2
53.97
2455
16524
(40758558) Short blood count panel - Blood
2392
16087
1.49
56.40
11.3
6.3
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
88
119
6.86
55.00
1.4
1.3
%
19.4
17.8
0.18
79
82
(3029937) Albumin [Presence] in Urine by Test strip
1306
17930
0.62
54.57
3.8
4.3
estimate
0.0
0.0
0.27
468
5604
(3023323) Follitropin [Units/volume] in Serum or Plasma
229
682
3.14
54.02
1.3
1.3
iu/l
30.8
32.5
0.28
181
579
(3000919) Neutrophils/100 leukocytes in Pleural fluid
137
288
4.43
53.49
1.3
1.4
%
15.2
21.4
2.11
129
254
(3001604) Monocytes [#/volume] in Blood
4198
31591
1.40
52.62
6.7
5.4
e9/l
0.7
0.6
39.35
3675
26698
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
120
232
4.81
51.87
1.5
1.4
%
16.0
22.3
1.76
106
185
(3006315) Basophils [#/volume] in Blood
4211
31817
1.39
50.93
6.7
5.4
e9/l
0.0
0.0
1.63
3700
26927
(3018010) Neutrophils/100 leukocytes in Blood
4007
30030
1.39
50.88
6.7
5.6
%
62.7
58.9
66.39
3874
27546
(3013707) Erythrocyte sedimentation rate by Westergren method
4340
47027
0.73
49.75
4.9
4.2
mm/h
22.2
14.5
92.53
4077
42571
(3026493) Urate [Moles/volume] in Serum or Plasma
1413
18693
0.64
49.01
2.8
3.0
umol/l
2564.8
5962.0
3.86
1177
15729
(3013650) Neutrophils [#/volume] in Blood by Automated count
4751
36796
1.37
48.39
15.1
8.3
e9/l
4.9
4.4
32.18
4292
31682
(40768804) Tissue Pathology biopsy report
3416
25142
1.39
47.31
2.9
2.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4239
32340
1.37
46.89
6.8
5.5
e9/l
1.7
1.9
3.74
3752
27810
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
164
433
3.53
46.87
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
186
534
3.25
46.64
1.5
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4275
32796
1.36
44.96
7.0
5.6
e9/l
0.2
0.2
6.45
3788
28117
(3011397) Hemoglobin [Presence] in Urine by Test strip
1121
15304
0.63
44.12
3.2
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3258
36530
0.73
44.03
4.4
3.1
u/l
71.4
57.2
6.02
2997
32925
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
322
1274
2.37
43.86
1.5
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
479
2253
2.01
42.29
1.5
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1473
9445
1.51
42.19
7.4
6.4
mmol/l
1.6
1.0
7.28
1238
7183
(3041096) Erythrocytes [Presence] in Urine by Automated
1250
16479
0.65
41.41
3.5
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2014
13803
1.43
40.92
5.5
3.1
mmol/l
2.5
2.5
65.43
1826
11828
(3019309) Folate [Moles/volume] in Red Blood Cells
1306
17013
0.66
40.69
1.7
1.8
nmol/l
1073.3
1153.4
2.40
975
12599
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1467
9469
1.50
40.56
7.4
6.4
kpa
5.3
5.0
20.42
1386
8941
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
604
3115
1.84
40.42
2.5
2.8
u/ml
0.3
0.3
1.59
344
1771
(3027801) Oxygen [Partial pressure] in Arterial blood
1465
9465
1.50
40.30
7.4
6.4
kpa
11.3
11.7
2.89
1383
8924
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
377
1656
2.14
39.97
1.5
1.5
—
—
—
0
0
(3013512) EKG study
1782
21809
0.70
39.74
4.5
4.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
390
1744
2.10
39.47
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
729
10752
0.59
39.20
1.2
1.2
u/ml
2.3
1.9
0.30
139
2665
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4571
35974
1.32
37.90
10.6
6.0
umol/l
9.9
12.7
37.93
4461
33958
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
563
8717
0.57
36.24
3.5
4.9
%
33.0
33.2
0.18
373
5652
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1647
19982
0.71
33.74
2.1
2.3
mg/l
3.4
3.1
4.83
1388
16741
(3021387) Prolactin [Units/volume] in Serum or Plasma
214
799
2.50
33.13
1.5
1.8
mu/l
321.9
296.6
0.75
209
741
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
617
9127
0.60
33.09
11.9
8.5
—
—
—
0
0
(3000492) Spirometry study
799
4708
1.61
32.80
1.6
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1885
22247
0.73
32.29
3.0
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4176
32907
1.30
32.28
7.9
6.0
mmol/l
1.2
1.2
6.31
3979
29309
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
292
1263
2.16
32.22
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4043
31803
1.29
31.35
7.4
11.7
inr
1.2
1.4
26.03
857
8709
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
259
1096
2.21
30.19
1.5
1.6
iu/l
3.0
4.4
2.18
45
326
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
636
3615
1.66
30.07
2.0
1.9
ug/l
1.8
2.5
0.78
574
3109
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
243
1007
2.25
29.80
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
246
1037
2.21
28.96
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
320
5473
0.52
28.72
1.6
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1075
6970
1.47
28.33
7.3
6.0
mmol/l
1.3
1.4
2.49
1024
6621
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
709
4208
1.59
28.13
9.8
8.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
260
1137
2.13
27.93
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
168
616
2.54
27.09
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
241
1046
2.15
26.41
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2565
19337
1.30
26.30
4.5
3.1
u/l
32.3
36.7
1.66
2457
18112
(3041918) Cholesterol [Moles/volume] in Pleural fluid
71
161
4.08
25.33
1.2
1.2
mmol/l
2.0
1.4
4.51
63
97
(3030905) Polymorphonuclear cells [#/volume] in Blood
267
1225
2.03
25.29
3.3
3.1
e9/l
5.0
4.5
2.91
267
1220
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
641
8853
0.64
25.07
1.2
1.3
iu/ml
47.8
39.9
0.49
183
2678
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
56
106
4.88
24.96
1.4
1.4
%
77.9
75.0
0.27
51
85
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
590
8277
0.63
24.77
1.2
1.2
u/ml
23.8
15.2
0.37
148
2871
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2675
29250
0.78
24.63
4.4
4.3
ng/l
62.7
86.5
0.45
2186
22980
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
203
846
2.23
24.63
1.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
205
862
2.21
24.34
3.1
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2217
16621
1.30
23.18
2.6
2.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
359
1878
1.79
22.88
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
359
1879
1.79
22.84
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3035
23692
1.26
22.81
5.7
3.3
mmol/l
2.4
2.3
16.16
2790
19983
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4442
36219
1.24
22.52
9.0
6.7
mmol/l
1.2
1.2
4.21
3781
30062
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
66
157
3.89
22.12
1.4
1.4
%
9.9
8.9
0.13
47
71
(3019060) Gas panel - Arterial blood
869
5662
1.45
22.09
4.3
4.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
277
1353
1.91
21.97
2.5
3.5
%
1.5
1.6
0.26
236
1002
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
128
461
2.58
21.50
1.7
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
351
1858
1.77
21.50
4.8
4.5
mmol/l
3.1
2.7
1.56
282
1241
(3013290) Carbon dioxide [Partial pressure] in Blood
351
1859
1.77
21.46
4.8
4.5
kpa
5.1
5.0
2.48
344
1806
(3027315) Oxygen [Partial pressure] in Blood
352
1867
1.76
21.42
4.8
4.5
kpa
8.1
8.4
2.64
345
1813
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
128
462
2.57
21.41
1.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
439
6377
0.62
21.33
3.5
3.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
125
448
2.59
21.22
4.3
3.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
160
644
2.31
21.14
1.3
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1217
8496
1.36
20.69
8.2
6.6
%
94.8
95.2
1.08
1173
8148
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
165
683
2.24
20.42
1.3
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
140
543
2.39
20.13
1.6
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2313
25285
0.79
20.09
2.9
3.3
ng/l
1533.3
2036.7
6.58
2084
21959
(3022145) Colonoscopy Study observation
509
7058
0.64
20.05
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
392
5761
0.61
19.97
1.9
2.1
ug/g
203.0
167.3
0.74
314
4416
(3002256) Pathology report gross observation
1258
8882
1.35
19.83
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
158
659
2.23
19.23
1.6
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3867
31411
1.22
19.19
6.0
4.7
g/l
32.5
34.3
63.99
3650
28709
(3022313) Gas panel - Capillary blood
605
3771
1.51
19.16
4.3
3.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
963
6550
1.39
19.15
8.6
7.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
124
466
2.47
19.12
2.8
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
292
4563
0.58
18.97
1.4
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
62
159
3.60
18.73
1.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
156
2933
0.48
18.63
1.7
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
345
1897
1.70
18.49
3.9
3.8
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
50
113
4.09
18.01
1.2
1.2
u/l
156.0
354.9
0.29
45
74
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1082
7597
1.35
17.57
8.7
7.1
g/l
120.1
120.0
0.04
1046
7315
(3010421) pH of Blood
373
2128
1.64
17.38
4.9
4.4
ph
7.4
7.4
1.54
344
1809
(40758047) Lysozyme [Mass/volume] in Pleural fluid
44
95
4.28
16.83
1.3
1.2
mg/l
6.4
8.5
0.86
44
88
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1776
13416
1.27
16.71
1.9
1.9
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
50
120
3.85
16.64
1.2
1.2
mmol/l
0.8
1.9
0.84
44
73
(3044640) Blood type and Crossmatch panel - Blood
2771
21998
1.22
16.59
2.8
2.6
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
39
78
4.62
16.38
1.1
1.1
iu/ml
34.8
11.9
0.68
15
35
(3020630) Protein [Mass/volume] in Serum or Plasma
1003
7040
1.35
16.27
1.9
2.5
g/l
64.8
65.9
5.16
933
6249
(3007164) IgA [Mass/volume] in Serum or Plasma
788
9696
0.73
16.03
1.4
1.5
g/l
2.7
2.7
0.03
450
5556
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
143
629
2.11
15.33
1.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
143
629
2.11
15.33
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
143
629
2.11
15.33
1.4
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
247
3813
0.59
15.30
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
324
4676
0.62
15.21
2.5
3.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
44
103
3.94
15.17
1.2
1.2
u/l
20.1
18.1
0.32
37
67
(3022217) INR in Platelet poor plasma by Coagulation assay
1050
12290
0.76
15.10
24.4
30.7
inr
1.4
1.5
1.09
138
1678
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
46
112
3.79
15.03
5.3
4.4
u/l
29.6
40.8
1.23
23
36
(36660697) Celiac disease serology panel - Serum
252
3850
0.59
14.99
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
125
527
2.20
14.93
2.1
2.0
e9/l
0.9
1.1
2.74
81
325
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
713
4814
1.39
14.73
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
267
3998
0.60
14.66
3.8
3.8
—
—
—
0
0
(3009343) pH of Capillary blood
766
5254
1.37
14.37
4.2
3.8
ph
7.4
7.4
0.16
72
666
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
743
5082
1.37
14.18
4.1
3.7
mmol/l
2.5
1.8
5.21
617
3667
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
863
6075
1.34
13.66
2.7
2.4
u/l
32.9
38.2
1.80
762
5113
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
445
2796
1.49
13.59
2.0
2.2
ug/l
355.8
652.8
1.29
400
2653
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
69
1562
0.40
13.49
1.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
78
280
2.58
13.37
1.4
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
78
280
2.58
13.37
1.4
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
766
5318
1.35
13.29
4.2
3.8
kpa
5.3
5.1
4.16
716
4861
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
293
4193
0.63
13.25
2.5
2.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
1281
0.35
13.23
2.4
1.6
mg/l
4.7
3.6
0.32
43
936
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
78
282
2.56
13.18
1.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1242
9226
1.27
13.16
1.9
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
275
1563
1.64
13.09
2.0
2.3
%
220.8
208.2
1.57
260
1478
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
147
2500
0.53
12.93
1.7
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
104
434
2.22
12.80
1.9
2.0
%
31.2
41.3
—
8
50
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
98
400
2.27
12.72
1.8
2.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
59
188
2.90
12.69
1.2
1.2
—
—
—
0
0
(4034850)
115
2098
0.50
12.65
14.3
12.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1239
9262
1.27
12.42
1.9
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5202
51278
0.85
12.41
14.6
7.5
u/l
88.6
82.0
14.79
5070
47742
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
93
376
2.29
12.36
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
93
377
2.28
12.28
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
93
377
2.28
12.28
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
93
377
2.28
12.28
1.4
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
288
1684
1.59
12.24
2.0
2.0
%
89.0
87.2
0.66
281
1587
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
96
396
2.24
12.17
1.8
1.9
%
13.8
15.6
0.47
29
158
(3037692) Legionella sp identified in Specimen by Organism specific culture
70
251
2.58
12.06
1.1
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
65
225
2.67
12.01
1.7
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2132
22547
0.83
11.89
2.3
2.2
u/l
157.2
229.8
10.94
2017
20971
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
130
2220
0.53
11.63
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1309
9920
1.25
11.61
7.7
6.5
mmol/l
103.6
104.6
10.05
1283
9672
(3039443) Prostate specific Ag panel - Serum or Plasma
39
1065
0.33
11.58
1.4
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
362
2261
1.49
11.43
4.0
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1111
12470
0.80
11.08
2.1
2.6
umol/l
10.2
12.0
12.35
1039
11358
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
291
1750
1.55
10.99
2.1
2.3
g/l
4.1
3.6
4.17
278
1646
(40768800) Prostate Pathology biopsy report
135
2237
0.55
10.93
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
763
8936
0.77
10.79
1.3
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
65
238
2.52
10.78
1.8
1.8
%
6.9
8.1
0.42
65
225
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
249
3524
0.64
10.74
2.3
2.4
au/ml
19.1
24.5
0.37
13
106
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1029
11611
0.79
10.73
2.1
2.6
g/l
2.2
2.2
3.29
960
10599
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
58
202
2.65
10.64
1.6
1.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
137
685
1.85
10.35
1.3
1.3
mosm/kgh2o
274.4
278.5
1.53
116
505
(3044416) Complement C4 [Mass/volume] in Pleural fluid
24
48
4.61
10.15
1.1
1.1
g/l
0.1
0.1
0.11
24
32
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
473
3179
1.39
10.08
4.8
4.2
mmol/l
25.7
24.7
8.76
451
2856
(44806118)
142
726
1.81
10.00
1.3
1.4
—
—
—
0
0
(44790048)
142
726
1.81
10.00
1.3
1.4
—
—
—
0
0
(44790047)
142
726
1.81
10.00
1.3
1.4
—
—
—
0
0
(44790049)
142
726
1.81
10.00
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
124
2050
0.55
9.99
1.3
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
229
1334
1.59
9.97
1.4
1.3
mmol/l
67.2
62.4
0.92
182
1080
(21494755) Public health laboratory ask at order entry panel
109
1869
0.53
9.94
1.2
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
157
830
1.75
9.89
2.4
3.4
%
59.6
59.1
0.08
118
502
(3017446) Testosterone [Moles/volume] in Serum or Plasma
408
5157
0.72
9.70
1.8
2.1
nmol/l
9.3
11.5
6.18
340
4360
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
89
392
2.10
9.68
1.8
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
225
3176
0.64
9.62
1.3
1.3
au/ml
24.3
61.8
—
10
129
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
38
111
3.16
9.56
1.1
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
137
706
1.80
9.43
2.8
3.6
u/ml
41.2
35.6
0.25
132
685
(3049717) Cytology report of Urine Cyto stain
306
4042
0.69
9.38
3.0
2.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
50
1104
0.41
9.35
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
237
1416
1.55
9.28
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
152
813
1.73
9.22
4.2
3.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
106
509
1.93
9.11
1.2
1.2
—
—
—
0
0
(4094501)
95
1631
0.53
8.75
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
340
2214
1.43
8.73
1.8
1.9
s
21.8
21.8
0.01
317
1981
(3000494) Fungus identified in Specimen by Culture
959
7245
1.24
8.66
1.5
1.4
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
11
11
9.21
8.66
1.3
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
82
368
2.06
8.55
2.4
2.0
e6/l
550.7
561.7
0.05
36
155
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
991
10948
0.81
8.37
2.2
2.7
%
19.4
21.7
5.23
882
9148
(3004588) Protein electrophoresis panel - Serum or Plasma
498
5971
0.75
8.36
2.1
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
84
384
2.02
8.34
2.2
3.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
212
1268
1.55
8.31
2.0
1.9
mmol/l
1.7
1.7
0.01
207
1235
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
197
1167
1.56
8.07
2.9
4.7
iu/ml
984.5
2764.9
0.57
25
171
(3017181) Myelocytes/100 leukocytes in Blood
780
5810
1.26
7.99
3.2
3.8
%
1.2
1.0
1.67
422
1771
(4024509)
28
726
0.35
7.63
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
243
1536
1.47
7.37
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
231
3066
0.69
7.33
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
75
1302
0.53
7.25
1.8
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
684
7738
0.80
7.19
2.3
2.5
ug/l
5.5
6.9
1.03
588
6551
(3014051) Protein [Presence] in Urine by Test strip
98
1567
0.57
7.13
2.0
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
39
836
0.43
6.90
1.9
1.6
—
—
—
0
0
(4015189)
52
214
2.24
6.82
2.0
2.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
296
1971
1.39
6.79
3.1
3.0
kpa
7.6
7.8
0.77
268
1820
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
68
314
2.00
6.66
2.7
2.6
%
36.7
36.1
0.05
18
116
(40767503) Oxygen content in Capillary blood by calculation
267
1753
1.41
6.65
2.6
2.6
%
14.5
15.8
3.97
107
950
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
389
2720
1.33
6.54
2.5
3.3
u/ml
556.4
2886.8
1.39
328
2327
(3021440) Promyelocytes/100 leukocytes in Blood
728
5514
1.23
6.44
3.3
3.9
%
0.2
0.1
1.21
393
1642
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
263
1733
1.41
6.43
3.4
2.8
mg/l
1.4
1.8
14.63
248
1538
(3023520) Reticulocytes [#/volume] in Blood
689
7689
0.81
6.38
2.4
2.5
e9/l
69.6
67.0
0.97
474
5933
(3006184) Hemoglobin [Mass/volume] in Capillary blood
279
1862
1.39
6.34
2.1
2.3
g/l
118.7
126.5
3.43
143
1378
(1761482) Bacteria [#/volume] in Urine by Culture
171
2321
0.67
6.17
4.6
4.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
507
3722
1.27
5.93
3.1
3.9
mmol/l
24.5
24.0
2.85
482
3295
(3008898) HLA-B27 [Presence]
66
1113
0.54
5.88
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
146
2022
0.66
5.85
2.3
2.2
ug/min
98.5
116.8
0.45
80
1145
(3000475) Leukocytes [#/volume] in Synovial fluid
123
1764
0.64
5.81
1.5
1.5
e6/l
31424.2
14705.1
0.77
93
1259
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
84
1320
0.58
5.81
1.1
1.3
u/l
45.3
38.0
0.28
70
1131
(4146454)
48
891
0.49
5.80
2.3
2.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
686
5223
1.22
5.79
3.2
3.7
%
0.7
0.7
0.12
317
1235
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
732
5614
1.22
5.75
1.6
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
202
2621
0.70
5.73
2.5
2.9
g/l
0.4
0.3
0.25
104
1126
(3021901) Oxygen saturation in Capillary blood
253
1694
1.38
5.68
2.9
2.9
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
68
333
1.89
5.68
2.4
2.0
e9/l
0.2
0.2
1.40
59
297
(1002224) Polysomnography panel
95
1438
0.60
5.67
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
76
1216
0.57
5.63
1.4
1.5
nmol/l
1.1
0.8
0.87
58
999
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
26
84
2.85
5.63
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
1144
0.56
5.61
1.7
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
480
5488
0.79
5.57
4.8
2.8
ml/min/173m2
61.4
60.0
0.35
196
2382
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49
889
0.50
5.55
1.6
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
428
4953
0.79
5.52
3.4
3.4
g/l
123.0
127.2
3.33
417
4825
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
70
350
1.85
5.50
2.4
2.0
e6/l
471.5
499.1
0.21
59
298
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
829
0.50
5.35
1.2
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2567
25557
0.90
5.16
3.6
4.0
e6/l
78.4
122.8
2.39
1963
19186
(3037522) Nuclear Ab [Titer] in Serum
641
7038
0.83
5.06
1.3
1.3
titre
483.2
499.6
0.10
162
1540
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
55
929
0.54
4.99
1.5
1.5
%
69.7
63.3
0.82
39
590
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
499
5596
0.81
4.88
2.9
3.9
ng/l
82.2
102.5
6.52
431
4696
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
230
2842
0.74
4.88
2.6
3.0
ratio
4.1
3.0
0.21
13
210
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
274
1910
1.33
4.81
2.2
4.1
u/ml
78.7
72.4
0.15
265
1830
(40768441) Liver Pathology biopsy report
75
401
1.73
4.77
1.2
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
239
2922
0.75
4.73
2.6
3.0
mg/l
49.8
86.7
1.14
185
2358
(3003327) Ova and parasites identified in Stool by Light microscopy
105
1479
0.65
4.65
1.5
1.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
48
225
1.97
4.63
1.1
1.9
u/ml
2102.3
28468.6
—
8
35
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
240
2918
0.75
4.58
2.6
3.0
mg/l
41.2
52.5
0.73
188
2353
(3027273) Bicarbonate [Moles/volume] in Venous blood
364
4193
0.79
4.56
3.8
3.6
mmol/l
25.9
25.0
4.79
353
4054
(3000570) Elastase.pancreatic [Mass/mass] in Stool
153
1994
0.70
4.54
1.3
1.4
ug/g
272.7
259.1
0.36
90
1225
(3032352) Blasts [#/volume] in Cerebral spinal fluid
16
44
3.35
4.53
1.5
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
742
5831
1.19
4.52
1.4
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
10
324
0.28
4.38
1.0
1.4
pmol/l
56.8
145.8
—
5
108
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
37
162
2.11
4.30
2.7
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
659
0.50
4.29
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
411
3067
1.24
4.27
1.2
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
42
729
0.53
4.24
1.7
2.1
u/field
3.6
1.8
0.67
20
276
(3017732) Neutrophils [#/volume] in Blood
369
4204
0.80
4.22
3.8
3.2
e9/l
5.1
4.2
4.25
284
2948
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
46
221
1.92
4.17
2.2
2.0
u/l
18.0
45.1
1.43
40
204
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
147
1897
0.71
4.15
1.7
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
289
3371
0.78
4.06
2.2
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70
1041
0.62
4.01
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
289
3363
0.78
3.99
2.2
2.2
g/l
4.0
3.8
0.66
219
2339
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
290
3373
0.78
3.99
2.2
2.2
g/l
8.0
7.4
4.82
224
2420
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
89
524
1.57
3.97
1.2
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
56
293
1.76
3.91
2.3
3.8
%
59.4
54.3
0.83
56
279
(3008536) Aspergillus sp Ab [Presence] in Serum
30
126
2.19
3.89
1.2
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
83
1177
0.65
3.87
2.7
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
254
0.33
3.81
2.7
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
129
1669
0.71
3.74
1.2
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
184
0.25
3.68
11.2
7.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
167
2067
0.74
3.68
1.6
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
21
77
2.51
3.67
1.8
2.2
ug/l
2.7
9.2
0.73
15
46
(3036005) Urine sediment comments by Light microscopy Narrative
6
5
11.05
3.58
1.0
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
43
701
0.56
3.57
1.3
1.5
%
20.0
25.9
0.77
29
447
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
169
1.96
3.53
1.6
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
51
790
0.59
3.50
1.0
1.1
iu/ml
9.3
261.6
0.64
12
153
(3015235) Bicarbonate [Moles/volume] in Capillary blood
306
2266
1.25
3.48
3.3
3.2
mmol/l
25.6
24.7
2.54
256
1983
(3000034) Microalbumin [Mass/volume] in Urine
45
716
0.58
3.43
2.0
3.1
mg/l
40.1
49.0
0.14
36
537
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
513
0.50
3.43
1.1
1.1
u/ml
3.1
3.5
0.11
11
145
(3000850) Epithelial cells [#/volume] in Urine
1635
16349
0.90
3.39
2.6
2.8
e6/l
5.9
4.1
6.54
1469
14365
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
14
43
3.00
3.37
1.1
1.1
u/field
1.5
0.9
—
8
28
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
118
1517
0.71
3.34
1.4
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
66
948
0.64
3.32
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
22
87
2.33
3.31
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1750
14869
1.10
3.25
4.5
4.2
ng/l
302.9
541.7
1.76
1526
12907
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
273
3112
0.80
3.22
2.3
2.3
g/l
3.4
3.1
6.16
222
2384
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
216
1551
1.29
3.19
1.7
1.8
mg/l
11.2
12.6
1.70
204
1413
(3000012) Reticulocyte production index
30
524
0.53
3.19
1.5
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
37
183
1.86
3.16
3.2
2.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
462
4991
0.84
3.13
1.7
1.7
%
1.8
1.6
3.68
362
4113
(3044941) Cell count panel - Synovial fluid
82
1110
0.68
3.12
1.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
101
1314
0.70
3.09
1.2
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
64
373
1.58
3.06
1.1
1.2
u/l
37.4
25.9
0.65
56
314
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
343
0.43
3.05
1.1
1.3
nmol/l
1.4
1.2
0.28
11
255
(3028433) Virus identified in Specimen by Culture
42
219
1.77
3.04
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
290
0.38
3.04
2.3
2.7
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
68
2.44
3.00
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
68
2.44
3.00
1.2
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
68
2.44
3.00
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
31
523
0.54
2.97
1.6
2.0
ug/l
2.0
2.1
0.12
26
435
(3025941) Bacteria identified in Stool by Culture
284
3192
0.81
2.96
1.3
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
74
0.00
2.93
0.0
4.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
18
69
2.40
2.92
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
919
7602
1.12
2.82
2.6
2.7
umol/l
8.6
10.1
0.89
805
6603
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
802
6587
1.13
2.77
2.1
2.1
g/l
0.2
0.2
0.32
753
6013
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
390
4225
0.84
2.77
1.4
1.6
g/l
2.0
1.5
11.11
328
3556
(3051593) INR in Capillary blood by Coagulation assay
30
499
0.55
2.76
6.1
12.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
138
1673
0.76
2.73
1.4
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
66
905
0.67
2.73
2.0
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
138
1668
0.76
2.68
3.7
3.8
mg/l
43.5
31.0
2.13
99
1107
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
48
271
1.63
2.66
2.3
2.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
297
0.43
2.65
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
117
1442
0.74
2.62
1.2
1.2
titre
147.1
101.2
0.35
14
107
(3001964) Herpes simplex virus Ag [Presence] in Specimen
34
175
1.79
2.61
1.1
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
46
674
0.63
2.61
1.4
1.7
u/ml
24.9
27.4
0.11
11
151
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
37
571
0.59
2.60
1.2
1.2
mmol/l
8.7
7.8
0.48
27
401
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1204
10158
1.10
2.58
4.6
5.6
mmol/l
1.0
1.0
1.16
1122
9258
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
18
4.09
2.58
4.8
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
18
4.09
2.58
2.4
3.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
293
0.44
2.57
1.3
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
343
0.48
2.56
2.4
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
629
5118
1.14
2.54
3.4
3.9
%
0.0
0.4
2.10
342
1360
(3020779) Urea [Moles/volume] in Serum or Plasma
903
7514
1.12
2.52
4.8
6.6
mmol/l
9.0
11.7
23.48
842
7035
(3027945) Reticulocytes/100 erythrocytes in Blood
1015
10241
0.90
2.51
2.2
2.3
%
1.8
1.7
0.23
900
8837
(4211845)
21
376
0.51
2.49
3.6
3.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
63
386
1.51
2.48
1.1
1.2
u/l
101.5
94.8
0.14
57
329
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
73
462
1.46
2.46
1.2
1.2
titre
167.7
117.8
0.21
13
77
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
130
907
1.32
2.46
1.8
2.4
u/ml
5684.4
1850.8
0.43
15
62
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
286
3144
0.83
2.44
2.2
2.2
g/l
10.2
10.4
0.45
237
2592
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
68
903
0.69
2.42
1.3
1.2
u/ml
69.0
45.2
—
8
100
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
146
0.31
2.42
1.0
1.5
ug/l
11.1
9.7
—
5
146
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
368
2890
1.18
2.41
3.8
3.1
pmol/l
4.2
4.3
1.09
334
2493
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
137
1630
0.77
2.41
1.8
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
163
0.34
2.40
10.2
11.7
mmol/l
0.7
0.6
—
6
150
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
439
3499
1.16
2.39
1.9
2.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
48
680
0.65
2.37
2.1
2.1
ml
608.6
643.5
0.19
29
408
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
255
2814
0.83
2.29
2.3
2.3
g/l
0.9
1.1
0.43
217
2341
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
338
2651
1.18
2.26
1.2
1.2
iu/ml
122.7
124.9
0.03
71
895
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
469
0.59
2.26
1.1
1.1
u/ml
0.6
1.7
1.43
12
184
(40760888) Immunoglobulin light chains.free panel - Serum
195
2207
0.81
2.26
2.5
3.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
12
43
2.57
2.25
1.2
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
47
658
0.66
2.22
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
66
864
0.70
2.20
3.7
4.0
umol/l
342.5
338.2
0.08
56
713
(3023410) Appearance of Cerebral spinal fluid
75
491
1.41
2.15
1.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1564
15361
0.92
2.14
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
53
718
0.68
2.14
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
114
1364
0.77
2.13
1.2
1.2
u/ml
18.2
36.0
0.85
13
71
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
244
0.45
2.10
2.4
1.5
ug/l
10.7
8.7
0.35
12
215
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
19
87
2.01
2.09
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
49
297
1.52
2.08
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
329
0.53
2.08
1.1
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
51
691
0.68
2.07
1.2
1.2
nmol/l
266.6
323.2
1.24
33
522
(3036670) Protein [Mass/volume] in Synovial fluid
14
265
0.49
2.02
1.1
1.2
g/l
44.7
39.9
—
5
133
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
133
0.35
2.02
1.0
1.6
ng/l
132.8
154.1
—
5
133
(3010144) Erythrocytes [#/volume] in Synovial fluid
54
719
0.69
2.01
1.4
1.3
e6/l
265097.0
156276.8
0.31
37
487
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1285
12682
0.92
1.99
2.8
3.0
e6/l
1.1
1.2
0.18
703
7588
(3047181) Lactate [Moles/volume] in Blood
310
2446
1.17
1.98
6.8
5.9
mmol/l
1.2
1.4
3.18
262
2173
(3016750) Collection duration of Urine
31
462
0.62
1.97
2.2
2.0
min
508.3
489.2
0.48
21
314
(3023183) Ammonium ion [Moles/volume] in Plasma
205
1559
1.21
1.97
1.9
2.4
umol/l
34.6
33.2
0.35
156
1260
(3016038) Potassium [Moles/volume] in Urine
73
485
1.39
1.96
1.2
1.1
mmol/l
35.7
35.2
0.07
65
406
(3004716) Salmonella sp identified in Stool by Organism specific culture
193
2147
0.82
1.94
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
63
409
1.42
1.93
1.5
1.6
u/l
5.7
6.2
0.12
39
187
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
13
53
2.26
1.90
1.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
108
1276
0.78
1.87
1.2
1.2
u/ml
2.3
5.5
0.78
13
128
(3036603) Volume of Urine
66
437
1.39
1.83
1.2
1.6
ml
2025.3
1841.2
0.52
34
119
(4198724)
16
73
2.02
1.80
1.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
124
1431
0.79
1.79
1.3
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
378
3054
1.14
1.79
1.3
1.5
u/ml
12.2
18.5
—
7
75
(3007853) Bacteria identified in Skin by Aerobe culture
958
8158
1.09
1.74
1.8
1.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
111
1290
0.79
1.71
1.2
1.2
u/ml
9.3
5.7
0.60
27
204
(3021589) Normoblasts [#/volume] in Blood
3110
27584
1.06
1.70
13.6
10.5
e9/l
0.0
0.0
0.36
2460
22366
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
113
820
1.27
1.70
2.8
3.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
92
1092
0.77
1.69
1.2
1.2
u/ml
1.0
5.2
—
9
77
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
46
0.00
1.68
0.0
1.2
—
1710.5
—
0
41
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
759
7595
0.91
1.65
2.8
3.1
ng/l
223.0
274.0
2.58
695
6966
(3008152) Bicarbonate [Moles/volume] in Arterial blood
633
5302
1.11
1.65
7.4
6.7
mmol/l
25.6
24.4
13.16
589
4953
(3004451) EKG impression Narrative
64
432
1.37
1.61
1.5
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
255
0.54
1.61
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
18
3.07
1.60
1.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
18
3.07
1.60
1.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
177
1941
0.84
1.58
1.2
1.2
u/ml
0.3
1.0
2.19
13
207
(3016018) Differential panel - Cerebral spinal fluid
78
546
1.32
1.56
1.4
1.3
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
11
46
2.20
1.54
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
558
5645
0.90
1.54
3.9
4.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
387
0.64
1.52
1.1
1.0
u/ml
0.6
1.2
0.71
12
155
(3019977) pH of Arterial blood
74
518
1.32
1.49
2.5
2.4
ph
7.4
7.4
0.49
27
202
(21494434) Karyotype in Bone marrow
57
708
0.74
1.48
1.1
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
96
697
1.27
1.48
1.1
1.2
u/l
65.3
64.2
0.04
79
459
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
394
0.65
1.46
1.0
1.0
u/ml
9.3
3.2
—
10
173
(3037756) Immunofixation for Serum or Plasma
180
1953
0.85
1.45
1.5
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
87
1.80
1.43
1.2
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
126
0.44
1.40
1.3
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
33
444
0.68
1.39
1.7
1.8
—
73.1
—
0
19
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
408
0.68
1.34
1.6
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
408
0.68
1.34
1.6
1.4
—
—
—
0
0
(3019225) pH of Specimen
772
7641
0.92
1.34
5.7
4.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
75
536
1.29
1.34
1.2
1.3
g/l
2.8
3.0
0.34
44
385
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
728
6212
1.08
1.32
5.8
3.9
mmol/l
1.2
1.2
2.03
689
5358
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
302
2466
1.13
1.30
1.7
1.7
u/l
37.1
38.0
0.37
262
2078
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
123
0.45
1.28
1.8
2.8
u/field
0.2
0.3
—
6
123
(3018572) Chloride [Moles/volume] in Blood
221
1769
1.15
1.28
7.7
6.6
mmol/l
104.0
105.1
2.53
190
1590
(3039000) Anion gap in Blood
221
1769
1.15
1.28
7.7
6.6
mmol/l
10.4
11.4
4.36
190
1590
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
223
0.58
1.25
1.4
1.4
—
1.4
—
0
16
(3026782) Osmolality of Urine
1738
15306
1.05
1.23
2.7
3.0
mosm/kgh2o
545.7
560.6
2.09
1519
13050
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
23
2.40
1.23
1.0
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
113
1.63
1.23
2.1
1.9
e6/l
37.5
1281.8
—
8
57
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
248
2587
0.88
1.23
2.3
2.1
g/l
36.4
37.1
0.99
216
2151
(3027135) IgG subclass 1 [Mass/volume] in Serum
74
536
1.27
1.21
1.2
1.3
g/l
6.7
7.1
0.46
42
380
(3024139) IgG subclass 3 [Mass/volume] in Serum
74
536
1.27
1.21
1.2
1.3
g/l
0.5
0.5
0.15
44
384
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
232
0.59
1.21
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
138
1500
0.84
1.19
1.3
1.4
—
—
—
0
0
(4062490)
74
538
1.27
1.18
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
184
0.55
1.18
1.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
36
235
1.41
1.17
1.2
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
24
2.30
1.17
4.0
5.5
—
—
—
0
0
(40758358) Immune stain study
6
24
2.30
1.17
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
195
0.57
1.17
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
33
427
0.71
1.16
1.6
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
31
0.00
1.16
0.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
193
2038
0.87
1.16
1.2
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
10
46
2.00
1.15
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
87
1.69
1.14
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
23
316
0.67
1.12
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
40
498
0.74
1.12
1.8
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
169
0.54
1.12
1.1
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
47
324
1.34
1.12
1.2
1.3
u/ml
0.4
1.7
1.67
27
175
(3017143) Hepatitis C virus Ab [Presence] in Serum
571
4865
1.08
1.11
1.4
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
40
269
1.37
1.11
1.1
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
15
226
0.61
1.11
2.3
1.4
umol/l
25.2
29.5
1.43
15
216
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
88
1.67
1.10
2.9
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
36
453
0.73
1.09
1.9
1.9
u/field
2.7
2.5
0.05
27
309
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
388
0.71
1.07
1.2
1.2
mmol/l
10.1
11.8
—
6
120
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
126
1365
0.85
1.07
1.4
1.2
mg/l
794.7
570.1
0.54
121
1272
(3020491) Glucose [Moles/volume] in Blood
41
504
0.75
1.07
2.1
2.2
mmol/l
7.5
7.2
0.34
32
342
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
115
0.48
1.05
6.7
12.9
mmol/l
5.5
5.2
—
6
115
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
42
512
0.75
1.04
1.4
1.6
—
1760.0
—
0
15
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
233
0.63
1.04
1.3
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
42
1.97
1.04
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
136
0.54
1.04
1.4
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
42
289
1.34
1.03
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
64
737
0.80
1.03
1.1
1.3
pmol/l
256.4
265.5
0.11
46
553
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
384
3230
1.10
1.02
1.7
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
239
2461
0.89
1.01
2.3
2.2
g/l
0.2
0.0
0.50
212
2199
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
196
0.61
0.98
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
71
803
0.81
0.98
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
135
1068
1.17
0.98
5.9
6.1
mg/l
11.6
12.2
0.75
127
962
(3014148) Varicella zoster virus Ab [Titer] in Serum
30
380
0.73
0.97
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
63
1.75
0.97
1.6
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
29
0.00
0.96
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
85
941
0.83
0.95
1.2
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
108
0.51
0.94
1.7
2.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
109
0.51
0.94
1.5
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
248
0.67
0.93
1.3
1.5
umol/l
16.7
16.8
0.00
11
173
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
138
1099
1.16
0.93
1.2
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
22
291
0.69
0.92
1.2
1.7
—
8.4
—
0
13
(44806420)
21
280
0.69
0.92
2.5
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
821
7981
0.94
0.92
4.9
3.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
593
5107
1.07
0.92
1.4
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
167
1745
0.88
0.91
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
562
0.78
0.91
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
40
280
1.32
0.90
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
246
0.67
0.90
1.1
1.1
ratio
1.1
1.1
—
5
71
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
92
1004
0.84
0.90
2.8
2.1
mg/l
32.2
27.2
0.31
32
246
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
94
0.49
0.89
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
256
0.68
0.89
1.1
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
13
190
0.63
0.88
1.2
1.1
—
8.5
—
0
17
(3014765) Yersinia sp identified in Stool by Organism specific culture
167
1739
0.88
0.88
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
166
1727
0.88
0.86
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
54
397
1.25
0.85
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
54
397
1.25
0.85
1.2
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
342
3419
0.92
0.84
6.3
5.0
%
0.9
0.9
0.71
308
3215
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
198
1629
1.12
0.84
1.5
1.6
iu/ml
48.6
12.8
0.34
61
411
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
12
176
0.63
0.84
1.0
1.1
%
112.8
91.9
1.54
12
127
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
176
0.63
0.84
1.6
2.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
198
0.65
0.83
2.1
2.4
mmol/l
6.4
7.9
—
8
131
(3002582) Erythrocytes [#/volume] in Urine
2422
22892
0.96
0.83
3.2
3.6
e6/l
83.3
117.8
0.94
1915
18113
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
36
252
1.32
0.83
2.1
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
36
252
1.32
0.83
2.1
2.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
22
0.00
0.79
0.0
1.4
—
1.3
—
0
22
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
22
0.00
0.79
0.0
1.8
—
2.5
—
0
16
(3027874) Urate [Moles/volume] in Urine
0
23
0.00
0.79
0.0
1.1
—
1.6
—
0
14
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
138
0.60
0.79
1.4
1.6
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
6.5
—
0.7
—
0
19
(3048929) Epstein Barr virus Ab [Presence] in Serum
105
1118
0.86
0.79
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
44
320
1.27
0.78
1.0
1.1
mg/l
63.3
44.6
1.20
36
265
(3052592) Norovirus Ag [Presence] in Stool
27
183
1.36
0.77
1.2
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
331
0.75
0.75
1.4
1.8
—
—
—
0
0
(44813793)
23
288
0.73
0.74
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
55
414
1.22
0.73
3.3
5.0
u/ml
152.2
56.6
0.50
16
119
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
51
1.62
0.73
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
201
0.69
0.71
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
106
849
1.15
0.71
1.2
1.4
u/ml
165.9
122.9
0.61
28
176
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
38
440
0.79
0.70
1.1
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
114
1194
0.88
0.70
1.3
1.2
mmol/l
3.8
3.9
0.21
107
1101
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
449
0.80
0.69
1.4
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
134
0.62
0.69
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
156
0.65
0.69
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
41
302
1.25
0.68
4.1
6.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
118
1229
0.88
0.67
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
352
3473
0.93
0.67
6.2
4.9
%
1.8
1.6
2.59
317
3266
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
17
109
1.44
0.67
1.0
1.2
—
9.8
—
0
6
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
84
0.55
0.67
1.6
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
74
796
0.85
0.66
1.1
1.2
u/ml
243.6
291.1
0.95
45
485
(3011985) Renin [Units/volume] in Plasma
73
786
0.85
0.66
1.4
1.4
mu/l
118.2
65.4
0.54
60
686
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
51
566
0.83
0.65
1.4
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
27
322
0.77
0.65
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
362
3561
0.93
0.64
1.9
1.8
g/l
1.4
1.4
0.18
326
3161
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
82
872
0.86
0.64
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
153
0.66
0.64
1.0
1.1
miu/ml
1588.0
1657.7
0.07
11
153
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
588
5694
0.95
0.64
1.3
1.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
8
120
0.61
0.63
1.3
1.3
—
99.3
—
0
19
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
63
683
0.85
0.63
1.2
1.2
miu/ml
164.1
209.4
0.42
14
207
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
32
231
1.28
0.63
1.4
1.5
umol/l
73.7
115.8
0.93
23
127
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
227
0.73
0.63
2.3
1.8
ug/l
41.1
59.4
1.51
18
219
(3024263) Appearance of Synovial fluid
35
402
0.80
0.63
1.2
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
20
135
1.36
0.61
1.3
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
162
0.68
0.61
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
162
0.68
0.61
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
162
0.68
0.61
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
162
0.68
0.61
1.2
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
114
1180
0.89
0.61
1.5
1.4
e6/l
22646.1
1034.7
0.51
82
962
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
140
0.66
0.61
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
114
1179
0.89
0.60
1.4
1.3
e6/l
43.7
24.7
0.34
80
908
(40761539) Cells [Type] in Urine sediment by Light microscopy
29
208
1.28
0.60
1.5
1.2
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
19
0.00
0.60
0.0
1.1
—
5.4
—
0
11
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
13
81
1.48
0.59
2.5
4.3
—
—
—
0
0
(4027681)
31
225
1.27
0.59
1.2
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
21
0.00
0.59
0.0
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
105
856
1.13
0.58
1.3
1.6
g/l
0.8
0.9
0.52
71
649
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
40
447
0.82
0.57
2.2
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
105
859
1.13
0.56
1.2
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
40
302
1.22
0.56
1.0
1.1
mg/l
414.1
303.8
1.32
35
257
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
114
1.37
0.55
1.1
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
18
221
0.75
0.55
2.4
1.8
mmol/l
0.9
0.5
0.14
18
204
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
147
0.69
0.54
1.5
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
39
295
1.22
0.54
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
658
6314
0.96
0.53
3.2
3.2
kpa
4.6
4.4
1.07
628
6052
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
70
560
1.15
0.53
1.4
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
167
0.72
0.53
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
36
402
0.82
0.52
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
69
552
1.15
0.52
1.2
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
22
260
0.78
0.52
1.1
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
58
1.43
0.52
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
92
0.60
0.52
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
66
698
0.87
0.52
1.4
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
88
717
1.13
0.51
1.2
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
60
1.38
0.50
1.3
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
31
231
1.24
0.50
1.5
1.7
nmol/l
17.0
5.1
0.42
26
200
(3034426) Prothrombin time (PT)
22
157
1.29
0.49
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
77
1.43
0.49
1.2
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
44
478
0.85
0.49
1.2
1.1
u/ml
87.4
83.9
—
8
18
(3018851) Theophylline [Moles/volume] in Serum or Plasma
13
85
1.41
0.49
1.6
1.5
umol/l
42.3
43.1
0.04
13
85
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
274
2366
1.07
0.48
1.5
1.5
titre
93.3
230.1
—
6
113
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
86
704
1.13
0.48
1.1
1.2
u/ml
5.2
5.0
0.03
26
219
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
386
0.83
0.46
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
233
2291
0.93
0.46
2.3
2.2
g/l
0.0
0.0
0.40
206
2039
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
70
567
1.14
0.46
1.2
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
23
265
0.80
0.46
2.2
2.0
e6/l
753.7
4165.0
0.60
16
184
(3028707) Methadone [Presence] in Urine by Screen method
30
226
1.22
0.45
1.2
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
202
1993
0.93
0.45
3.1
3.1
nmol/l
0.8
0.8
0.04
160
1509
(3035320) C reactive protein [Mass/volume] in Body fluid
59
474
1.15
0.44
2.5
2.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
100
1017
0.90
0.44
7.1
15.0
mmol/l
7.6
7.5
0.10
85
824
(3021447) Carbon dioxide [Partial pressure] in Venous blood
863
7692
1.04
0.44
3.4
3.8
kpa
6.0
5.8
3.66
827
7413
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
11
140
0.72
0.44
1.0
1.3
%
94.0
80.5
—
6
74
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
83
683
1.12
0.44
1.2
1.2
u/ml
4.2
4.5
0.11
34
298
(3025018) Bordetella pertussis Ab [Titer] in Serum
18
212
0.78
0.43
1.2
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
28
1.64
0.43
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
51
540
0.87
0.43
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
45
481
0.86
0.43
1.2
1.2
u/ml
17.2
39.6
—
6
36
(3012565) Volume of 24 hour Urine
30
332
0.83
0.42
2.1
2.3
ml
1635.4
1836.0
0.56
23
273
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
84
0.66
0.42
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
81
830
0.90
0.42
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
30
1.53
0.41
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
128
0.72
0.41
1.1
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
14
0.00
0.41
0.0
1.4
—
2.1
—
0
14
(3041672) Baker's yeast Ab [Presence] in Serum
0
14
0.00
0.41
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.41
0.0
4.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
54
567
0.88
0.41
1.0
1.1
au/ml
7.9
10.4
—
5
19
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
38.0
—
0
5
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
15
0.00
0.41
0.0
5.0
—
377.3
—
0
15
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
18.2
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
400
0.85
0.41
2.1
2.3
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
16
0.00
0.40
0.0
1.1
—
333.2
—
0
5
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
16
0.00
0.40
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
16
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
230
2248
0.94
0.40
2.3
2.2
g/l
0.0
0.0
0.00
206
2031
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
129
1093
1.09
0.40
1.1
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
12634.7
—
0
6
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
290
1.17
0.39
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
859
7679
1.03
0.39
3.5
3.8
mmol/l
2.3
1.8
3.37
720
6129
(3024869) Neuronal Ab [Presence] in Serum
20
147
1.25
0.38
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
360
1.15
0.38
2.1
1.5
u/l
132.1
1686.4
1.07
15
123
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
60
490
1.13
0.37
1.2
1.2
%
95.8
94.3
0.20
55
447
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
118
1000
1.09
0.37
1.2
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
103
0.71
0.37
1.3
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
34
1.35
0.37
1.2
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
106
0.69
0.37
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
206
0.80
0.36
1.1
1.6
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
70
0.66
0.36
1.4
1.3
—
816.3
—
0
11
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
113
0.73
0.35
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
285
1.16
0.35
1.4
1.5
nmol/l
0.4
0.2
0.62
30
211
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
37
393
0.87
0.35
1.3
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
40
1.38
0.34
1.3
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2219
20719
0.98
0.34
3.1
3.4
e6/l
0.6
0.5
1.29
1728
16054
(3005033) Fetal Nuchal fold Thickness US
6
80
0.69
0.33
1.2
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
80
0.69
0.33
1.2
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
36
381
0.87
0.33
1.9
2.2
mmol/l
8.3
9.3
1.02
28
296
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
83
0.66
0.33
1.5
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
286
2513
1.05
0.32
4.3
4.1
mmol/l
3.9
3.9
0.33
265
2331
(3032057) Clostridioides difficile [Presence] in Stool
19
213
0.82
0.32
2.1
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
30
320
0.86
0.31
1.2
4.1
mg/l
58.8
66.7
0.34
20
216
(3024932) HLA-DR beta [Type]
11
131
0.77
0.31
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
15
171
0.81
0.30
1.1
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
140
0.79
0.29
1.2
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
52
1.24
0.29
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
43
444
0.89
0.29
1.2
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
472
4479
0.97
0.28
2.4
2.6
g/l
10.0
10.7
3.31
431
4047
(3028300) Cannabinoids [Presence] in Urine
45
462
0.90
0.28
1.2
1.8
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
22
238
0.85
0.27
2.2
1.9
e6/l
5201.2
16700.2
0.72
15
136
(3044242) Glucose [Moles/volume] in Arterial blood
44
451
0.90
0.27
2.2
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
178
0.83
0.27
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
138
0.80
0.26
1.7
3.0
—
—
—
0
0
(3024471) HLA-A [Type]
12
138
0.80
0.26
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
45
460
0.90
0.26
1.2
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
217
0.85
0.26
1.2
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
52
434
1.10
0.26
2.5
2.2
ug/min
84.9
181.6
—
9
107
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
127
0.80
0.25
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
137
0.81
0.25
1.0
1.1
%
94.1
82.0
—
7
69
(3033705) Calcium.ionized [Moles/volume] in Venous blood
120
1171
0.94
0.25
3.0
2.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
124
1078
1.06
0.24
1.4
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
36
296
1.12
0.23
1.1
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
155
0.83
0.23
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
111
1082
0.94
0.23
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
145
0.82
0.23
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
342
3246
0.97
0.22
4.8
4.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
85
0.76
0.22
1.1
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
181
1594
1.05
0.22
2.0
3.1
u/ml
142.5
767.5
2.53
162
1457
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
171
1645
0.96
0.22
1.7
1.4
g/l
1.1
1.2
1.21
159
1549
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
38
1.21
0.22
1.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
141
1.17
0.22
1.7
2.0
ug/l
1.0
1.1
0.14
18
132
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
112.8
—
0
5
(3028714) Urate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
10
0.00
0.21
0.0
5.9
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
43
434
0.91
0.21
1.1
1.2
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
39
1.18
0.21
2.4
9.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
42
424
0.91
0.21
1.2
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
97
0.76
0.21
1.1
1.7
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
159
1.16
0.21
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
45
452
0.92
0.20
1.2
1.8
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
13
0.00
0.20
0.0
6.3
—
42.5
—
0
13
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.20
0.0
2.2
—
3.0
—
0
13
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
133
0.83
0.20
1.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
262
2491
0.97
0.20
1.2
1.3
—
—
—
0
0
(4281824)
54
537
0.92
0.20
1.1
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
103
0.80
0.20
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2124
19736
0.99
0.20
3.1
3.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
59
584
0.93
0.19
3.1
3.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
29
297
0.90
0.19
1.4
2.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
35
354
0.91
0.19
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
35
354
0.91
0.19
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
35
354
0.91
0.19
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2337
21687
0.99
0.18
4.1
2.5
u/l
58.9
59.8
0.31
2192
19907
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
559
5044
1.02
0.17
1.8
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
22
228
0.89
0.17
1.8
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
10
75
1.23
0.17
1.2
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
121
0.84
0.17
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
24
197
1.12
0.17
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
23
237
0.89
0.17
2.5
2.8
umol/l
30.2
29.2
0.22
18
176
(3026389) Candida sp identified in Specimen by Organism specific culture
89
777
1.05
0.17
1.3
1.4
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
58
1.11
0.17
1.0
1.7
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
61
0.75
0.17
10.4
12.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
22
227
0.89
0.17
2.5
2.6
—
33.0
—
0
6
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
63
1.17
0.16
1.3
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
130
0.85
0.16
2.2
4.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
90
788
1.05
0.16
1.2
1.3
nmol/l
0.2
0.3
—
8
57
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
35
350
0.92
0.15
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
35
350
0.92
0.15
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
35
350
0.92
0.15
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1486
13537
1.01
0.15
1.7
1.7
mg/l
1.9
1.5
1.85
1219
10583
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
71
0.78
0.15
1.2
1.1
u/l
16.7
10.1
—
6
71
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
15
158
0.87
0.15
1.3
2.0
%
191.5
205.2
0.22
15
145
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
311
0.92
0.15
1.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
94
1.17
0.14
2.3
2.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64
557
1.06
0.14
1.1
1.1
iu/ml
2.1
2.1
—
5
25
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
182
1.11
0.14
1.3
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
147
1.13
0.14
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
195
0.90
0.13
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
97
0.85
0.13
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
40
393
0.94
0.12
1.4
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
10
78
1.18
0.12
1.1
1.5
—
—
—
0
0
(4212803)
11
87
1.16
0.12
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
87
833
0.96
0.12
1.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
231
0.92
0.11
1.1
1.1
u/l
1.0
1.1
0.66
13
114
(3011648) Oxygen content in Venous blood
58
508
1.05
0.11
2.2
1.9
%
11.2
10.9
0.19
58
508
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
24
240
0.92
0.11
1.0
1.1
iu/ml
6.3
12.8
—
9
59
(3017569) Oxygen content in Arterial blood
45
436
0.95
0.10
2.6
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
21
210
0.92
0.10
2.5
1.9
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
42
1.10
0.09
4.0
3.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
42
1.10
0.09
1.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
71
629
1.04
0.09
1.1
1.2
%
121.9
113.7
1.27
65
544
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
44
1.05
0.09
1.0
1.1
—
13.8
—
0
8
(3003740) Influenza virus B Ag [Presence] in Specimen
47
412
1.05
0.09
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
178
1604
1.02
0.09
2.1
2.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
169
1588
0.98
0.08
1.6
1.4
g/l
0.2
0.2
0.73
157
1494
(3050794) Legionella sp Ab [Presence] in Serum
6
52
1.06
0.08
1.3
1.1
—
—
—
0
0
(44806071)
6
53
1.04
0.08
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
54
1.02
0.08
1.7
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
57
0.81
0.08
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
104
0.88
0.08
1.6
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
78
741
0.97
0.08
1.1
1.1
g/l
1.6
1.6
0.83
70
661
(40760892) CBC W Ordered Manual Differential panel - Blood
1376
12586
1.01
0.08
5.3
4.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
4482
41342
1.00
0.08
7.1
4.9
mmol/l
6.8
6.9
6.53
4327
38884
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
62
1.04
0.08
1.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
69
0.80
0.07
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
69
1.07
0.07
1.6
1.5
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
71
1.04
0.07
6.0
4.2
ug/min
76.8
59.0
—
8
58
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
74
0.87
0.07
3.3
2.2
—
71.6
—
0
13
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
44
422
0.96
0.07
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
94
887
0.97
0.07
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
85
803
0.97
0.07
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
75
710
0.97
0.06
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
30
262
1.05
0.06
2.4
2.2
u/ml
916.9
1461.4
1.21
30
256
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
94
0.88
0.06
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
94
0.88
0.06
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
94
0.88
0.06
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
94
0.88
0.06
1.3
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
97
872
1.02
0.06
2.4
2.3
u/ml
293.4
973.6
0.84
92
856
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
17
145
1.08
0.06
1.1
1.1
—
—
—
0
0
(4306422)
68
644
0.97
0.06
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
307
2856
0.99
0.06
1.2
1.3
u/ml
261.9
265.9
0.03
276
2610
(3025468) Yersinia sp identified in Specimen by Organism specific culture
98
882
1.02
0.06
1.2
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
130
0.92
0.05
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
98
883
1.02
0.05
1.2
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
158
0.93
0.05
9.0
11.8
nmol/l
985.7
773.3
0.60
16
150
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
13
110
1.09
0.05
1.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
83
1.11
0.05
1.2
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
157
0.94
0.04
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
98
886
1.02
0.04
1.2
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
296
0.96
0.04
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
84
1.10
0.04
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
97
907
0.98
0.04
1.2
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
412
1.03
0.03
1.2
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
17
165
0.95
0.03
10.9
16.9
nmol/l
1852.5
1370.6
0.56
17
160
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1306
11994
1.00
0.02
2.9
3.3
e6/l
2.5
1.7
2.07
726
6950
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
118
1095
0.99
0.01
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
159
1.04
0.01
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
96
892
0.99
0.01
1.2
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
47
425
1.02
0.01
1.2
1.2
promille
1.3
1.1
0.44
36
328
(3025130) Human papilloma virus identified in Specimen
30
283
0.98
0.01
1.8
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
70
652
0.99
0.01
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
68
633
0.99
0.01
1.0
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
37
347
0.98
0.01
1.2
1.1
nmol/l
11.7
11.6
0.01
17
79
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
144
0.96
0.01
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
116
0.95
0.00
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
74
687
0.99
0.00
1.3
1.3
nmol/l
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
18
171
0.97
0.00
2.9
2.6
mu/l
10.4
21.6
1.84
18
159
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3358
30906
1.00
0.00
4.4
4.3
—
—
—
0
0
(4268621)
49
446
1.01
0.00
2.1
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
26
241
0.99
0.00
2.0
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
46
422
1.00
0.00
1.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
20
189
0.97
0.00
1.2
1.5
g/l
13.8
14.4
0.11
14
150
(4133840)
14
126
1.02
0.00
1.4
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
38
347
1.01
0.00
1.2
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
93
0.99
0.00
1.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
110
1.00
0.00
1.3
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
127
1.01
0.00
1.6
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
32
293
1.00
0.00
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
32
293
1.00
0.00
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
25
235
0.98
0.00
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
17
154
1.02
0.00
1.1
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
49
0.94
0.00
1.0
1.2
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
1.5
—
0
7
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
73
0.88
0.00
1.6
1.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
60
0.92
0.00
1.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
60
0.92
0.00
1.3
1.1
mmol/l
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
49
0.94
0.00
1.2
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
64
1.01
0.00
1.0
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
169.8
—
0
5
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
63
0.88
0.00
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
68
0.95
0.00
1.1
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
50.6
—
0
5
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.4
—
0.2
—
0
5
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
87
0.95
0.00
1.1
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_RESPIRATORY_INTRATHORACIC – Malignant neoplasm of respiratory system and intrathoracic organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).